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 The word “synapse” (συν + απτειν, or clasping together) was first coined in the late 19th 
century, amidst an explosion of anatomical studies into the structure of neurons in the brain 
(Hortsch, 2009). The etymology reflects its structure and function – the tight apposition of an 
axon onto its postsynaptic target (in the brain, usually a dendrite) is required for the synapse to 
become a portal of communication between the neurons of the brain. Neurons in the central 
nervous system form an extraordinary number of synapses with each other: for example, in 
visual cortex of an adult human, there are approximately 300 million synapses in one cubic 
millimeter and an individual cortical neuron can receive on the order of ten thousand synapses 
(Huttenlocher, 1990). The inputs a neuron receives are diverse, with unique electrophysiological 
characteristics, and the neuron sends outputs onto many distinct cells within the neural circuitry. 
In some ways, the formation of a synapse between two neurons is akin to meeting up with a 
friend in Grand Central at rush hour – it requires careful communication on time and location to 
achieve that desired “clasping together” of a handshake. And this coordination must occur amidst 
numerous neurons throughout the brain simultaneously. Synapse development is caught between 
discrete and broad demands – one, to assemble a fully functional synapse between correct 
synaptic partners, and two, to simultaneously ensure coordinated synapse formation throughout 
the brain. As an illustration, the hippocampal neural circuit (which will be the focus of my work 
in the following chapters) demonstrates many of these principles of coordination (Figure 1.1): 
coordination of specific synapses onto one dendrite, such as excitatory versus inhibitory 
synapses to ensure proper excitatory-inhibitory balance (Figure 1.1 B), coordination of synapse 
development throughout a region, for example clonally-related excitatory neurons preferentially 
















Figure 1.1. Coordination of synapse development in the brain.
A) An example of a neural circuit: Major excitatory projections in the hippocampal 
formation. Inputs from Entorhinal cortex (EC) to dentate granule cells (DGC) in dentate 
gyrus to CA3 Pyramidal Neurons to CA1 Pyramidal Neurons out to subiculum. Local 
interneurons provide inhibitory tone. 
B) An example of synapse coordination between different synapses onto the same 
neuron: Balance of inhibitory synapses from interneurons and excitatory synapses from 
the dentate gyrus (DG) onto CA3 pyramidal neuron.
C) An example of synapse coordination in parallel: development of synapses between 
DGCs and CA3 throughout the hippocampus.
D) An example of synapse coordination across regions: synapses formed between 





synapses between regions, such as coordination of the inputs and outputs across a neuron (Figure 
1.1 D). In this chapter, I will discuss basic events of synapse development, delve into the 
underlying molecular mechanisms, and finally outline current evidence in support of abnormal 
synapse development leading to neurological disease in humans. I will use this as a backdrop to 
explain the role of two synaptogenic molecules, FGF22 and FGF7, in inducing excitatory and 
inhibitory presynaptic differentiation in area CA3 of the hippocampus. What are the mechanisms 
through which the synaptogenic FGFs coordinate synapse development? This is a question I will 
address in the remainder of my thesis. 
 Synapse development occurs during late gestational and early postnatal development, and 
encompasses a phase of remarkable neural network emergence en route to a mature brain. 
Careful observation of postmortem human brain of various ages using electron microscopy by 
Patricia Goldman-Rakic and Pasko Rakic, among others, demonstrated that the first synapses 
appear at 5 weeks gestation and continue to increase exponentially in infancy until they peak in 
number at 2 years of age – in visual cortex at nearly 200% of mature brain count – and then 
steadily decrease until they finally achieve the “mature” number of synapses in the third decade 
of life (de Graaf-Peters and Hadders-Algra, 2006; Tau and Peterson, 2010). In terms of absolute 
numbers, synapse development can be divided into stages (Bourgeouis, 1997): First, synapses 
appear at a slow rate and occupy a low-density of neural tissue, at a time when neurogenesis (the 
birth of new neurons) is still ongoing. Next, a phenomenal acceleration of synapse formation 
occurs, coinciding with the end of neurogenesis and overlapping but extending past axon and 
dendrite elaboration. In humans, this huge addition of synapses starts in the second trimester of 
pregnancy and continues until the 2nd year of age, when synapse number peaks. These synapses 
are then slowly pruned away over the next decade of human life, through puberty, and then until 
the third decade of life, when the “mature” state is finally achieved (Petanjek et al., 2011). The 
rate of synapse formation and elimination does not occur simultaneously in different brain 
regions: even within the cerebral cortex of humans, the dynamics of synapse development vary, 
with areas of cortex for sensory input developing first and prefrontal areas last (Huttenlocher and 
Dabholkar, 1997). The general pattern of cortical synapse development is conserved among 
many species – for example in rodents, the exponential phase of synapse addition extends for 
two weeks starting after birth, peaks at postnatal day 28 (P28), and stabilizes at around P40  
(Bourgeois, 1997; Bhatt et al., 2009); furthermore, many of the molecules involved in synapse 
3
formation and function are highly conserved across species (Ryan and Grant, 2009). Thus, 
rodents provide important experimental vertebrate models for understanding normal and 
pathological synapse development (Nestler and Hyman, 2010). 
 Zooming in on individual synapses reveals that synapses are highly specialized 
structures. Simplistically, the activated presynaptic neuron releases neurotransmitter into the 
synaptic cleft, which is then received by the postsynaptic neuron: hence, at the presynaptic side 
there are neurotransmitter-laden synaptic vesicles and the machinery required for activity 
dependent release at the axon terminal, and on the postsynaptic side are the receptors that 
respond to the neurotransmitter and the associated machinery important for modulating the 
response in the dendrite. But synapses in the brain are structurally, molecularly, and 
physiologically diverse (Walmsley et al., 1998). Presynaptically, neurons produce distinct 
neurotransmitter, which instruct its role in the neural circuit: excitatory neurons produce 
glutamate, which activates the postsynaptic neuron, inhibitory neurons produce GABA, which 
suppresses the postsynaptic neuron, and neuromodulatory neurons produce acetylcholine, 
dopamine, or serotonin, depending on the identity, which modulate transmission at excitatory 
and inhibitory synapses (in great simplification). Beyond neurotransmitter identity, diverse 
synaptic boutons throughout the nervous system contain different stereotypic numbers of 
synaptic vesicles, from two hundred synaptic vesicles at an excitatory synapse in CA1 to over 
twenty thousand vesicles at mossy fiber boutons, the synapses between dentate granule cells and 
CA3 pyramidal neurons (Harris and Sultan, 1995; Rollenhagen et al., 2007). The active zone 
contains protein machinery that is important for docking synaptic vesicles and releasing them in 
response to an increase in calcium (usually elicited by an action potential), including RIM, 
Bassoon, Munc13, and SNARE proteins, as well as voltage-gated calcium channels (Dresbach, 
2015; Imig et al., 2014). Postsynaptically, dendrites must segregate neurotransmitter receptors to 
the appropriate synapses – glutamatergic receptors, such as NMDA-type or AMPA-type 
receptors to excitatory synapses, GABAergic receptors to inhibitory synapses. The morphology 
of excitatory postsynaptic sites is often further specialized into a dendritic spine – a protuberance 
from the shaft of the dendrite that serves in part to electrically isolate individual excitatory 
synapses on a dendrite (Yuste, 2013). Excitatory and inhibitory poststsynaptic densities have 
numerous proteins in the postsynaptic density that are important for distinct function – for 
example postsynaptic density protein PSD95 is found at excitatory synapses, gephyrin is at 
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inhibitory synapses, as well as numerous metabotropic receptors, potassium channels, and even 
elements of local translational machinery (Sheng and Kim, 2011). Synapses are complex and 
highly specialized structures; it is not surprising that their assembly should require many levels 
of control.   
Time-lapse studies of assembly of individual synapses in vitro and in vivo have revealed 
that it is a multi-step and highly dynamic process (Figure 1.2). In neuronal culture, synapses 
appear to assemble within hours of initial contact, with the presynaptic components typically 
preceding the postsynaptic components (Friedman et al., 2000). Presynaptic components are 
trafficked along the axon as transport packets, containing a number of synaptic vesicles or active 
zone proteins forming a complex (Ahmari et al., 2000) and accumulate at the nascent synapse.  
Synaptic vesicle transport packets pause along the axon at fixed sites, in a synapsin-, calcium-, 
and actin-dependent manner, even in the absence of postsynaptic contact, where the synaptic 
vesicles release neurotransmitter, suggesting an intrinsic predisposition to form hemisynapses 
within the axon (Sabo et al., 2006). However, in the presence of appropriate postsynaptic 
contacts, synaptic vesicles accumulate at nascent synapses and outcompete inappropriate sites 
lacking postsynaptic contact, preventing ectopic synapse formation (Allen et al., 2008). Synaptic 
vesicles and active zone proteins are trafficked separately; elements of the active zone can recruit 
other presynaptic proteins, for example the active zone protein Bassoon directly recruits voltage-
gated calcium channels (Davydova et al., 2014). Not all the components of the presynaptic 
terminal assemble simultaneously at the nascent synapse: first synaptic vesicles assemble, then 
active zone proteins, followed by components of the synaptic vesicle release machinery, such as 
synapsin, whose recruitment is controlled by Cdk5 (Easley-Neal et al., 2013), suggesting that 
distinct stages of presynaptic assembly can be regulated by distinct signals. The elements on the 
postsynaptic side also arrive at the nascent synapse independently.  Clusters of NMDA-type 
glutamate receptors are transported in packets (akin to the synaptic vesicle and active zone 
packets presynaptically), bound to postsynaptic density components such as EEA1 or SAP102 
(Washbourne et al., 2002). The recruitment of NMDA receptor components can be independent 
of recruitment of PSD95 (Washbourne et al., 2002), suggesting that there may be numerous and 
simultaneous processes of postsynaptic protein recruitment. In contrast, the postsynaptic density 
protein, PSD95, is not only transported along the dendrite as a packet, but also accumulates at 




















Figure 1.2. Schematic of excitatory and inhibitory synapse development.
Synapse development begins with axo-dendritic contact. Synaptic vesicle and active zone 
proteins accumulate in active zone terminal presynaptically. Excitatory synaptic vesicles 
contain glutamate, inhibitory synaptic vesicles contain GABA. Postsynaptically, glutamate 
receptors and excitatory postsynaptic density proteins (for example PSD-95) accumulate 
at nascent excitatory synapses in the dendrite; GABA receptors and inhibitory 
postsynaptic density proteins (such as Gephyrin) at inhibitory nascent synapses. Nascent 




























cytosolic pool or by splitting from pre-existing postsynaptic densities that are apposed to a 
presynaptic terminal (Bresler et al., 2001). Dynamics of inhibitory synapse formation in culture 
are similar to excitatory synapse formation although the dynamics may be slower (Dobie and 
Craig, 2011) – de novo synapses appear over 8 hours, with presynaptic protein accumulation 
preceding postsynaptic protein accumulation by 2 hours; and synapses are often mobile as a 
presynaptic-postsynaptic unit (Dobie and Craig, 2011). Again, components of the synaptic 
densities can themselves recruit other proteins: Gephyrin, the postsynaptic density protein at 
inhibitory synapses, is required for clustering of GABA receptors at inhibitory postsynaptic 
densities (Jacob et al 2005). The fact that presynaptic components assemble before postsynaptic 
components (at least in vitro) and that they spontaneously exocytose neurotransmitter at pause 
sites suggests that the released neurotransmitter could facilitate the accumulation of the 
appropriate receptors (glutamatergic receptors to glutamate, GABAergic receptors to GABA) at 
the nascent synapse on the dendrite. Indeed, NMDA-type glutamate receptors that are trafficked 
along dendrites are routinely exocytosed to sample the extracellular space (Washbourne et al., 
2004). As further support, blocking synaptic vesicle release in retinal ganglion cells leads to 
fewer synapses in the retina (Kerschensteiner et al., 2009): a contributing mechanism to the loss 
of synapses could be a failure to appropriately recruit synaptic machinery. Furthermore, synapses 
are highly dynamic both in vitro and in vivo, and immature synapses tend to be more dynamic 
than mature synapses (Koleske, 2013). Live imaging in vivo in the cortex of developing 11-day-
old (P11) mice revealed that dendritic spines can form and retract within two hours (Lendvai et 
al., 2000). Younger animals have higher dynamics of spine formation and retraction than older 
animals, although turnover does persist into the adult brain (Lendvai et al., 2000; Bhatt et al., 
2009), supporting the notion that elevated dynamics of synaptic structure turnover are an 
important part of development. In fact, filopodia-like spines have a higher motility and are more 
likely to form transient contacts with presynaptic boutons, compared to spines with more 
“mature” structure, that are less likely to be motile and more likely to form more stable contacts 
with presynaptic boutons (Konur and Yuster, 2004). Presynaptic boutons turn over as well: in 
mature hippocampus, when there is no net change in synapse number, presynaptic boutons turn 
over on a scale of one to three days (De Paola et al., 2003). Dynamic changes in synapse 
structure and molecular composition are both an inherent feature of synapses, and an important 
aspect of synapse development. 
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Synapse development occurs on a dynamic backdrop. Firstly, synapse formation occurs 
concurrently with other major events of brain development, including neurogenesis and neurite 
elongation (Tau and Peterson, 2010). In some cases, synaptic partners are born at different times, 
and one mechanism of ensuring their ultimate connectivity is for earlier born neurons to synapse 
onto temporary synaptic partners to await their final postsynaptic targets, for example preplate 
neurons in the cortical plate provide a synaptic target for thalamic input in the time before layer 4 
pyramidal neurons are born (Chao et al., 2009). Axons and dendrites are still elaborating as 
synapses are formed (Becker et al., 1984). Cajal-Retzius cells provide a synaptic target for 
entorhinal cortical input into the hippocampus in the time before pyramidal dendrites have 
elaborated into the stratum lacunosum moleculare (Chao et al., 2009). The relationship between 
synapse formation and the growing nervous system is bidirectional. Synapse formation 
reciprocally affects neurogenesis: immature synapses from parvalbumin-positive interneurons 
are an important survival cue for proliferating dentate gyrus neurons (Song et al., 2013). Synapse 
formation and activation also stabilizes developing axons and dendrites as they grow and branch, 
preventing their retraction (Alsina et al., 2001; Meyer and Smith, 2006; Rajan and Cline, 1998; 
Rajan et al., 1999; Li et al., 2000; Niell et al., 2004; Sin et al., 2002). Thus, there is a reciprocal 
relationship between “earlier” stages of development, such as neurogenesis and neurite growth, 
and synaptogenesis. 
Secondly, the electrophysiological properties of the neural circuit change, which affects 
how developing synapses function within the network. In the mature brain, GABAergic signaling 
is inhibitory, but during early postnatal development, GABAergic signaling is excitatory, 
because of a shift in the intracellular chloride concentration at the end of the first week 
postnatally (Ben-Ari et al., 1997; Kerschensteiner, 2013). Another change in the developing 
neural network is in the distribution of glutamate receptor types at excitatory synapses: over the 
course of development there is an increase in the ratio of AMPA-type to NMDA-type glutamate 
receptors and within the subunits of the NDMA-type glutamate receptors themselves there is a 
gradual replacement of GluN2B subunits (which contains a C terminus CaMKII binding region) 
by GluN2A subunits (which do not have this C terminus region). The change in NMDA receptor 
subunit composition is critical to synapse development: prolonged overexpression of GluN2B 
prolongs spine motility, while premature expression of GluN2A decreases spine density and 
volume, and decreases spine motility (Gambrill and Barria, 2011). Interestingly, GluN2B has 
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opposite effects in synapse formation in excitatory and inhibitory neurons: GluN2B delays the 
formation of glutamatergic synapses onto excitatory neurons, but promotes excitatory synapse 
formation onto inhibitory synapses (Kelsch et al., 2014). The switch in NMDA-type glutamate 
receptor subunits may be an important mechanism contributing to balanced formation of 
excitatory and inhibitory tone in the neural network. The shift in GluN2B and GluN2A subunits 
also does not happen in all regions of the brain, but it is correlated with a shift in NMDA-type 
glutamate receptor coagonist: in the hippocampus, the switch occurs in the synapses between 
CA3 and CA1 pyramidal neurons, but not at the synapses from entorhinal cortical neurons onto 
dentate granule cells; there is a concurrent shift in NMDA-type glutamate receptor coagonists 
released in these regions – serine (preferentially used by GluN2A) starts to be expressed at the 
time of the subunit switch in the CA1, but glycine (preferentially used by GluN2B) remains 
released in the dentate gyrus (Le Bail et al., 2015). This suggests that there is co-regulation of 
presynaptic and postsynaptic aspects of the physiological change at glutamatergic synapses. 
Thus, the electrophysiological properties of synapses undergo important shifts during 
development that directly affect synapse development. 
Thirdly, the neural network requires constant neural activity for its survival and 
appropriate development from its inception (Kerchenstein, 2013; West and Greenberg, 2011). 
Neural activity is generated by a combination of spontaneous waves of activity and sensory input 
into the neural circuit. Activity is important in driving many aspects of neural development. 
Deletion of a SNARE protein that is required for the exocytosis of synaptic vesicles, Munc18-1, 
does not impair the initial formation of brain circuits, but without neurotransmitter release, the 
neurons then progressively degenerated through apoptosis, suggesting that the maintenance of a 
functional brain requires constant activity and/or that neurotransmitters themselves are trophic 
(Verhage et al., 2000). Neuron depolarization controls gene expression: depolarization of 
dendrites induces an increase in intracellular calcium, which regulates the transcription factors 
NFAT, CREB, and NPAS4, and these in turn control both synapse formation and excitatory 
versus inhibitory synapse balance (West et al., 2002; West and Greenberg, 2011). Activity of the 
circuit and molecular control of synapse formation form a reciprocal relationship in controlling 
synapse development.  
Thus, synaptogenesis is happening on the backdrop of a dynamically developing nervous 
system, with changes in the architecture of the neural circuit, the electrophysiological properties 
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of the circuit, and constant neural activity running through the circuit. Given the complexity of 
the process and of the final outcome, synapse formation requires strict molecular control to 
ensure appropriate assembly of synaptic machinery at the correct locations (Craig and Boudin, 
2001; Shen and Cowan, 2010; Dabrowski and Umemori, 2011). Molecules exchanged between 
pre- and postsynaptic partners serve to promote the formation of synapses between appropriate 
synaptic partners and with appropriate synaptic machinery, ultimately leading to unique, 
specialized synapses in the brain. Molecules that are able to induce presynaptic or postsynaptic 
differentiation are called synaptic organizers, and simplistically can be categorized into cell 
adhesion molecules and secreted molecules.  
 Synaptogenic cell adhesion molecules include neurexins/neuroligins, SynCAMs, leucine-
rich repeat proteins (LRRs), and some cadherins (reviewed in de Wit and Ghosh, 2014; Missler 
et al., 2012; Craig and Kang, 2007; Arikkath and Reichardt, 2008). The synaptogenic cell 
adhesion molecules are transmembrane proteins, with relatively short intracellular domains 
compared to their long, extracellular domains containing many “sticky” protein motifs. A general 
principal for their mechanism of action is transsynaptic binding – either homophilic (the same 
molecule is expressed both presynaptically and postsynaptically and binds to itself across the 
synapse, for example SynCAM1 or cadherins) or heterophilic (different molecules are expressed 
presynaptically and postsynaptically, for example neurexins, which are presynaptic, bind to 
neuroligins, which are postsynaptic). Transsynaptic binding allows recognition of synaptic 
partners: for example, specific sets of LRRs are expressed at distinct synapses in the 
hippocampus, such as excitatory projections from entorinal cortex versus CA3 onto CA1 
pyramidal neurons or different subsets of inhibitory synapses in CA1 (de Wit and Ghosh, 2014; 
Tomioka et al., 2014). Cell adhesion molecules promote synapse maturation and stabilization: 
The cell adhesion molecule IgSF9/Dasm1 regulates inhibitory synapse development in the CA1 
of the hippocampus, and does so purely through transsynaptic binding, independent of its 
cytosolic domain (Mishra et al., 2014). Postsynaptic calsyntenin3 (which belongs to the cadherin 
family) interacts transsynaptically with neurexin in interneurons to induce inhibitory synapses 
(Lu et al., 2014; Um et al., 2014), while calsyntenin1 is required postsynaptically at excitatory 
synapses to stabilize developing dendritic spines in CA1 (Ster et al., 2014). Loss of NCAM 
destabilizes dendritic spines  (de Paola et al., 2003). Postsynaptic LAR-RPTP binds 
transsynaptically to Slitrk, which then clusters laterally within the presynaptic terminal to induce 
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presynaptic differentiation (Um et al., 2014), suggesting that one mechanisms of synapse 
differentiation driven by adhesion molecules is to form homomeric clusters. Cell adhesion 
molecules and synaptic density proteins reciprocally affect each other’s synaptic localization – 
the postsynaptic density protein Dlg5 is required for dendritic spine formation by delivering N-
Cadherin to the surface (Wang et al., 2014). Expression of synaptogenic cell-adhesion molecules 
drives distinct aspects of synapse maturation. The regulation of N-Cadherin expression is 
coordinated with synapse maturation by co-transport of N-Cadherin together with AMPA-type 
glutamate receptors through the scaffolding protein GRIP1, which promotes dendritic spine 
growth in hippocampal cultures (Heisler et al., 2014). Calsyntenin1 promotes the NMDA-type 
glutamate subunit switch from GluN2B to GluN2A in CA1 (Ster et al., 2014). Although many 
cell adhesion molecules promote synapse development through direct recruitment of synaptic 
proteins via protein-protein interactions, some transsynaptic cell adhesion molecules promote 
synapse differentiation through downstream signaling, for example Eph/Ephrin signaling, where 
transsynaptic binding of the Eph receptors activates their tyrosine kinase activity (Hruska and 
Dalva, 2012). Synaptogenic cell adhesion molecules are important for organizing presynaptic 
and postsynaptic densities, and for recognition of synaptic partners via direct binding in the 
extracellular matrix.  
 Secreted synaptic organizers include fibroblast growth factors (FGFs), insulin-like 
growth factors (IGFs), Wnts, and Sonic hedgehog (Shh) (Dabrowski and Umemori, 2011; 
Johnson-Venkatesh and Umemori, 2010; Williams and Umemori, 2014, Harwell et al., 2012). 
Secreted molecules function through activating specific receptors that then induce presynaptic 
and/or postsynaptic assembly through signaling pathways. Secreted molecules can have both an 
autocrine (onto the same neuron it was secreted from) and paracrine (onto the neuron across the 
synaptic cleft) effect; secreted molecules can also function through numerous receptors to induce 
distinct aspects of synapse differentiation. Wnts (Wnt5a and Wnt7a) are important for both 
presynaptic and postsynaptic differentiation (Salinas, 2012). In vivo, in the cerebellum, Wnt7a is 
a retrograde signal required for presynaptic differentiation (including both synaptic vesicle 
accumulation and synaptic vesicle recycling) onto cerebellar granule cells; in the hippocampus 
Wnt7a induces dendritic spines in areas CA3 and CA1 (Hall et al., 2000; Ahmad-Annuar et al., 
2006; Cerpa et al., 2008). In cultured hippocampal neurons, Wnt7a induces both presynaptic and 
postsynaptic differentiation at excitatory synapses through distinct mechanisms, and Wnt5a 
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induces excitatory presynaptic differentiation and both excitatory and inhibitory postsynaptic 
differentiation. Presynaptically, Wnts act through three receptors - two Frizzled receptors (which 
are G-protein coupled receptors) and Ror (a receptor tyrosine kinase receptor). The mechanisms 
of presynaptic differentiation (in vitro both synaptic vesicles and active zone proteins 
accumulate) are transcription-independent, and involve Dishevelled signaling (downstream of 
Frizzled receptors) and inhibition of Gsk3 signaling, although further mechanisms of synaptic 
vesicle and active zone recruitment are not yet known (Davis et al., 2008; Varela-Nallar et al., 
2009; Sahores et al., 2010; Paganoni et al., 2010). Postsynaptically, Wnts utilize distinct 
signaling pathways from presynaptic pathways, and distinct signaling between excitatory and 
inhibitory postsynaptic differentiation: both Wnts induce calcium signaling in the dendrite, and 
additionally Wnt7a induces PSD-95 clustering at excitatory synapses through a mechanism 
involving Dishevelled and CaMKII; Wnt5a induces PSD-95 clustering through a mechanism 
involving JNK, but GABA receptor clustering at inhibitory synapses through CaMKII (Cuitino 
et al., 2010; Ciani et al., 2011; Farias et al., 2009). Thus, Wnts have a complex role in synapse 
development through utilization of many distinct signaling pathways. Another retrograde signal 
that acts through a still different set of signals to induce presynaptic differentiation is Shh, which 
is secreted by layer 5 cortical neurons to induce presynaptic differentiation at synapses from 
layer 2/3 cortical neurons (Harwell, 2012). Here, presynaptic differentiation does not require 
canonical Shh-induced Gli-dependent transcription, but instead the Shh co-receptor Boc is 
required, possibly utilizing Src kinase signaling.  
 Finally, FGFs, which will be the focus of the remaining chapters of this dissertation, 
induce synaptic vesicle accumulation in axon terminals (Umemori et al., 2004; Terauchi et al., 
2010; Dabrowski and Umemori, 2011). There are twenty-two FGFs in mice and men, although 
only eighteen are secreted, these bind to seven FGF receptors (FGFRs), which are receptor 
tyrosine kinases (Ornitz and Itoh, 2015). Among the secreted FGFs, only a subset induces 
synaptic vesicle clustering in vitro in cultured neurons (Umemori et al., 2004), and of these the 
roles of FGF22 and FGF7 have been best demonstrated in vivo. FGF7, FGF10, and FGF22 were 
first identified as a presynaptic organizing molecule in the cerebellum and neuromuscular 
junction (Umemori et al., 2004, Fox et al., 2007). Interestingly, in the CA3 region of the 
hippocampus, FGF22 and FGF7 are both secreted from CA3 pyramidal neurons (Terauchi et al., 
2010; Terauchi et al., 2015) but function at distinct axon terminals: FGF22 induces synaptic 
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vesicle accumulation at excitatory synapses, but FGF7 acts as a presynaptic organizer at 
inhibitory synapses (Terauchi et al., 2010). Thus, FGF22 and FGF7 provide synapse-specific 
differentiation cues (Figure 1.3). However, the mechanisms through which FGF22 and FGF7 
induce specific presynaptic differentiation were unknown. Thus, there is still much to be learned 
about the distinct signaling pathways that induce presynaptic differentiation. 
 In order to limit synapse formation and prevent ectopic, oversized, and/or supernumerary 
synapses, there must also be negative regulation. Negative regulators during synapse 
development limit synapse formation or growth; additionally molecules that promote synapse 
elimination during later stages of brain development will prune away already formed synapses: 
loss of either negative regulators or molecules promoting synapse elimination will result in 
supernumerary or oversized synapses in the mature brain. One example of a negative regulator is 
a secreted semaphorin, Sema3F (Tran et al., 2009), which acts through a complex of the 
receptors neuropilin-2 and plexin-A3 (Tran et al., 2009), and the adhesion protein NrCAM 
(Demyanenko et al., 2014), to repress dendritic spine formation in subsets of neurons in the 
visual cortex and in the dentate gyrus. A transmembrane semaphorin, Sema5A, also negatively 
regulates dendritic spine density on dentate granule cells, cell-autonomously via binding the 
receptor plexin-A2 in cis (Duan et al., 2014). Similarly, the three mammalian Nogo receptors 
cooperate to repress dendritic spine density in hippocampal CA3 and CA1 in vivo (Wills et al., 
2012). Slit1a negatively regulates synaptic vesicle accumulation, in part through its receptor 
Robo2, within axons of retinal ganglion cells in zebrafish (Campbell et al., 2007). Protocadherin 
17 negatively regulates presynaptic differentiation in striatum at synapses from cortical neurons 
(Hoshina et al., 2013). Thus, multiple levels of negative regulation in a synapse-specific manner 
provide crucial signals for synapse development. 
 In addition to molecular cues exchanged between the presynaptic and postsynaptic 
neurons, the balance between specific synapse formation and broad coordination of synapse 
formation throughout the brain is also informed by cues from astrocytes and microglia. Because 
of their ability to sample broadly across populations of neurons by forming extensive contacts 
with thousands of neurons, astrocytes and microglia may provide an important mechanism of 
coordination of synapse development in parallel (Figure 1.1 C). The role of glia in 
synaptogenesis was first demonstrated by Barres and colleagues, when they demonstrated that 
neuronal media in which glia were first grown had a very strong synaptogenic effect in vitro  
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Figure 1.3. The role of FGF22 and FGF7 in presynaptic differentiation.
FGF22, secreted from CA3 dendrites, induces excitatory presynaptic differentiation. Excitatory 
synaptic vesicles can be visualized by detecing vesicular glutamate transporter 1 (VGLUT1).
FGF7, secreted from CA3 dendrites, induces inhibitory presynaptic differentiation. Inhibitory 
synaptic vesicles can be visualized by detecting vesicular GABA transporter (VGAT). 






















(Ullian et al., 2001). Since then, the role of astrocytes and microglia has been increasingly 
appreciated.  
 Astrocytes closely contact synapses, poised for their many roles in modulating synapse 
formation and function (Chung et al., 2015). Astrocytes promote both excitatory and inhibitory 
synaptogenesis through direct contact via the γ-protocadherins – loss of astrocytic expression of 
γ-protocadherin leads to lower excitatory and inhibitory synapse number embryonically that 
recovers in early postnatal development (Garrett and Weiner, 2009). Astrocytes also secrete 
numerous factors to induce synaptogenesis. Thrombospondins are secreted during early synapse 
development and induce excitatory synapse formation (Christopherson et al., 2005) through 
binding to the calcium channel subunit Cacna2d1 (Eroglu et al., 2009), although the synapses 
induced by thrombospondins are silent, and require further signaling for full maturation. TGF-β 
secreted by astrocytes onto nascent synapses induces increased excitatory synapse number 
through upregulating D-serine expression, which is a coagonist of NMDA receptors (Diniz et al., 
2012). During later stages of development, between P14 and P25, hevin and SPARC are secreted 
from astrocytes to modulate excitatory synaptogenesis (Kucukdereli et al., 2011; Risher et al., 
2014). Interestingly, hevin induces growth of excitatory presynaptic boutons, but SPARC 
directly antagonizes it: how relative hevin and SPARC expression is controlled is unknown. 
Furthermore, in cortical layer 2/3, hevin specifically promotes presynaptic maturation of inputs 
from the thalamus (VGLUT2-positive) over inputs from cortex (VGLUT1-positive) (Risher et 
al., 2014), suggesting a role of astrocytes in controlling synapse specificity amidst a population 
of neurons. Thus, astrocytes can use numerous mechanisms to coordinate synaptogenesis 
throughout development across a larger population of neurons that are in parallel neural circuits 
but not necessarily in direct contact with each other. 
 Microglia, once thought of as merely the macrophages of the central nervous system, also 
have important roles in synapse formation (reviewed in Salter and Beggs, 2014; Ueno and 
Yamashita, 2014). Microglia directly contact synapses in a highly dynamic manner (Tremblay et 
al., 2010). Microglia express trophic signals such as IGF-1 (Ueno et al., 2013) that may have 
important instructive roles in synapse maturation. Indeed, loss of CX3CR1 receptor in microglia 
leads to delayed maturation of excitatory thalamocortical synapse maturation in barrel cortex – 
the synapses have a delay in the increase of AMPA-type to NMDA-type glutamate receptor ratio 
and GluN2B to NR2A subunit switch (Hoshiko et al., 2012). Similarly, loss of the 
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transmembrane polypeptide DAP12 in microglia causes a failure in the functional glutamate 
receptor rearrangement in maturating synapses in hippocampus (Roumier et al., 2004). 
Furthermore, microglia have an important role in later stages of excitatory synapse maturation, 
indirectly, through controlling synapse elimination by direct engulfment of eliminated synapses 
through a mechanism co-opting the immune system complement signaling (Stevens et al., 2007; 
Paolicelli et al., 2011; Bialas and Stevens, 2013; Chu et al., 2010). Thus microglia, like 
astrocytes, have the ability to coordinate synapse formation across populations of neurons. 
Whereas astrocytes appear to control synapse formation throughout development, and especially 
in early stages of synaptogenesis, microglia appear to have a role predominantly in coordinating 
later steps of synapse maturation, such as functional glutamate receptor rearrangements and 
synapse elimination.  
Synapses are essential to how information is processed in the brain; therefore it is 
intuitively obvious that defective synapse formation leads to neuropsychiatric disease (Williams 
and Umemori, 2014; Melom and Littleton, 2011; Spronsen and Hoogenraad, 2010; Blanpied and 
Ehlers, 2004; Zoghbi, 2003).  There are many ways in which failure of synapse development can 
lead to disease: failure to form connections between the correct synaptic partners (or formation 
of connections between inappropriate synaptic partners) can lead to an alteration in the areas of 
the brain that are connected resulting in altered information processing (which is thought to 
underlie both schizophrenia and autism); similarly, failure to form fully functional synapses can 
cause the right connections to form but with inappropriate synaptic weight, leading to failures in 
information propagation (which can underlie schizophrenia, autism, mental retardation or 
epilepsy); failure of synapses to acquire the ability to have changes in synaptic plasticity can lead 
to altered learning (which is thought to be a contributing factor to addiction); and failure of 
synapses to maintain healthy structure throughout life can lead to neurodegeneration (for 
example in Alzheimer’s disease). Many of the neurodevelopmental disorders, especially mental 
retardation, autism, epilepsy, and schizophrenia, appear to have overlapping etiologies, and 
sometimes even co-occur in patients (Guilmatre et al., 2009). Autism incidence overlaps with 
both mental retardation and epilepsy, especially in certain syndromic causes of autism, such as 
Tuberous Sclerosis, Fragile X Syndrome, or Rett Syndrome (Philips and Pozzo-Miller, 2015; 
Tuchman and Rapin, 2002). Schizophrenia can overlap with epilepsy, both due to common 
circuits being engaged in epilepsy-associated psychosis, but also due to overlapping genetic 
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causes (Cascella et al., 2009). The broad disease phenotypes, the overlaps between the 
neuropsychiatric diseases, and the multiple genetic and developmental routes underlying 
neuropsychiatric diseases reflect the wonderful complexity and terrifying delicacy of neural 
circuit formation. 
There are four lines of evidence for defects in synapse pathology leading to 
neuropsychiatric disorders: 1) disease time course; 2) synaptic changes found in human patients; 
3) genetic studies identifying synapse-related genes in human patients; and 4) animal models 
with mutated or deleted synaptic genes. The time course of emergence of such diseases as autism 
or schizophrenia in humans coincides with important events in synapse development (Andersen, 
2003; Rubenstein, 2011). Autism is a developmental disorder characterized by impaired social 
skills and repetitive behaviors and typically manifests around two years of age after overtly 
normal infantile development, at the time corresponding to the peak of synapse number. In fact, 
children with autistic brains appear to have initially smaller brains at birth that then grow to be 
larger than average (Courchesne et al., 2003). Schizophrenia, a psychiatric disease that includes 
symptoms such as delusions, hallucinations, and disorganized thinking, typically manifests in 
late adolescence and early adulthood. In a theory first put forth by Feinberg (Feinberg, 1983), the 
onset of schizophrenia is thought to be linked to aberrant pruning of synapses and aberrant neural 
circuit refinement. Anatomical findings in post-mortem tissues from affected human patients also 
point to defects in synapses. Using dendritic spines (the excitatory postsynaptic dendritic 
protrusion) as a morphological readout, investigators found changes both in autistic and 
schizophrenic brains. In syndromes linked to autism, there are changes in dendritic spine 
morphology and density, but the changes differ between syndromes – in Tuberous Sclerosis there 
is an increased density in dendritic spines, in Fragile-X spine density is not changed but the 
synapses stay thin and filopodia persist without maturing, and in Rett and Angelman syndromes 
spine density is decreased and spines are less mature (Phillips and Pozzo-Miller, 2015). In 
schizophrenic brains, density of dendritic spines appears to decrease specifically on cortical layer 
3 pyramidal neurons, suggesting defective connectivity within a subset of circuits (Moyer et al., 
2014). Numerous studies have probed the genetic underpinning of neuropsychiatric diseases and 
found that networks of numerous synaptic proteins and proteins that are important for synapse 
formation are perturbed in autism (De Rubeis et al., 2014), schizophrenia (Mirnics et al., 2000; 
Mirnics et al., 2001; Nascimento and Martins-de-Souza, 2015), and epilepsy (Noebels, 2015). 
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Variations in FGFR2, which will be discussed in the remaining chapters, have been linked to 
autism, major depressive disorder, and Pfeiffer syndrome, which includes intellectual delay and 
seizures (De Rubeis et al., 2014; Williams and Umemori, 2014). Behavioral and morphological 
phenotypes in animal in which synapse-formation genes are knocked out lend further support to 
the importance of synapse formation in appropriate brain function (Williams and Umemori, 
2014; Grone and Baraban, 2015; Nestler and Hyman, 2010). Mice lacking FGF7 or FGF22 have 
disrupted excitatory and inhibitory balance leading to altered susceptibility to seizure induction, 
which will be discussed in later chapters. Thus, there is strong evidence that aberrant synapse 
development can lead to neuropsychiatric disease. Targeting synaptic function and the overall 
neural circuitry has potential for therapeutic benefits in neuropsychiatric disease. Indeed, many 
neurological and psychiatric drugs target the synapse (Miyamoto et al., 2012; Rudolph and 
Konflach, 2011; Schousboe et al., 2014). The future holds great promise of new therapies, such 
as genetically reprogramming stem cells derived from patients and reintroducing them into 
diseased brain in extreme cases of otherwise unmanageable neurological disease (Parent and 
Anderson, 2015), and there is still a great need for more precise and effective therapies. 
 
 In this thesis, I will describe my work on elucidating the mechanisms through which 
FGF22 and FGF7 form a balanced hippocampal network. I will first demonstrate the receptors 
through which FGF22 induces excitatory presynaptic differentiation and FGF7 inhibitory 
presynaptic differentiation (Chapter 2); I will then describe the functional localization of the 
receptors to the presynaptic neuron and the signaling pathways through which FGFRs induce 
presynaptic differention (Chapter 3). Finally, in Chapter 4, I will describe a new line of 
experiments addressing FGF-induced gene expression and the potential role of synaptogenic 
FGFs in coordinating synapse development across a neuron (see Figure 1.1 D). This is an 
important contribution to understanding the mechanisms synapse formation, with implications 
















Identification of Synaptogenic FGF Receptors 
 
The following work is in press for publication in the journal Development as: Dabrowki, A., 
Terauchi, A., Strong, C., and Umemori, H. (2015) Distinct sets of FGF receptors sculpt 
excitatory and inhibitory synaptogenesis. 
 
 
 Introduction.  
 
Neurons of the developing brain must form a network of excitatory and inhibitory 
synapses in a highly organized fashion, which requires differential molecular control between 
each synapse type (Chia et al., 2013; Dabrowski and Umemori, 2011; Jin and Garner, 2008; 
Johnson-Venkatesh and Umemori, 2010; McAllister, 2007; Sanes and Yamagata, 2009; Shen 
and Scheiffele, 2010; Siddiqui and Craig, 2011; Williams and Umemori, 2014; Williams et al., 
2010). An imbalance between excitatory and inhibitory drive in the brain may lead to various 
neurological and psychiatric diseases including epilepsy, autism, and schizophrenia (Lisman, 
2012; Southwell et al., 2014). Thus, the components of molecular signaling mediating synapse 
formation are key factors in the vulnerability or resilience to such disorders. Hippocampal 
circuits are critical to memory formation, emotional processing, and social behavior. The 
hippocampal circuits consist of highly organized synaptic connections, in which excitatory 
projections relay from the entorhinal cortex (EC) to the dentate gyrus (DG) to CA3 to CA1 to the 
EC, and are balanced by inhibitory inputs from local interneurons. In the hippocampus, two 
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fibroblast growth factors (FGFs), FGF22 and FGF7, are secreted from dendrites of CA3 
pyramidal neurons and promote presynaptic differentiation of excitatory and inhibitory synapses, 
respectively (Terauchi et al., 2010). That this FGF-dependent regulation of excitatory and 
inhibitory presynaptic differentiation is important for proper brain development is evidenced by 
altered seizure susceptibility of knockout (KO) animals: Fgf22-KO mice have decreased, and 
Fgf7-KO mice increased susceptibility to epileptic seizures (Terauchi et al., 2010; Lee et al., 
2012; Lee and Umemori, 2013). However, the signaling mechanisms underlying FGF-dependent 
synapse formation are not understood. Understanding the mechanisms through which FGF22 and 
FGF7 specifically promote excitatory and inhibitory presynaptic differentiation will give an 
important insight into how molecular signaling tunes discrete synapse formation.  
 
FGFs regulate a variety of processes, including cell proliferation, migration, 
differentiation, tissue repair, and response to injury in almost all organs (Thisse and Thisse, 
2005; Turner and Grose, 2010; Ornitz and Itoh, 2001). In the nervous system, FGF signaling is 
important in various steps of development including neural induction, patterning, proliferation, 
axon guidance, and synapse formation (Guillemot and Zimmer, 2011; Jones and Basson, 2010; 
Mason, 2007; Stevens et al., 2010a; Umemori, 2009). For the eighteen secreted FGFs, there are 
four FGF receptors (FGFRs), which, through b and c splice variants, encode seven distinct 
receptor tyrosine kinases (Chellaiah et al., 1994; Johnson et al., 1991; Ornitz et al., 1996; Belov 
and Mohammadi, 2013; Powers et al., 2000). Once FGFRs are activated, they recruit and/or 
phosphorylate a number of signaling molecules including fibroblast growth factor receptor 
substrate 2 (FRS2), phosphoinositide 3-kinase (PI3K), and phospholipase C γ (PLCγ), which 
result in the activation of downstream pathways (Mohammadi et al., 1996; Furdui et al., 2006; 
Bae et al., 2009; Lemmon and Schlessinger, 2010). Therefore, the cellular responses to FGFs are 
regulated at multiple levels by a number of different factors. What is remarkable in FGF-
dependent synapse formation is that FGF22 and FGF7 are secreted from the same CA3 
pyramidal neurons but specifically organize excitatory or inhibitory presynaptic differentiation. 
Important questions to ask regarding their specific effects include the identity of the receptors, 
location of their action, and the signaling pathways involved. Understanding the precise FGF 
signaling mechanisms during excitatory and inhibitory synapse development will not only 
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further our understanding of synaptogenesis, but will also yield more insight into how FGFs 
dictate cellular outcomes with such remarkable specificity.  
 
 
In this chapter, I will address the following important questions regarding the 
mechanisms of FGF-induced excitatory and inhibitory synapse formation: What are the receptors 
through which FGF22 and FGF7 mediate their synaptogenic effects? Using multiple null and 
conditional knockout mice and primary cultures prepared from them, I found that distinct but 
overlapping sets of FGFRs mediate excitatory versus inhibitory synapse differentiation. My work 
uncovers mechanisms of FGF-induced specific presynaptic differentiation and contributes to a 
profound understanding of how appropriate neural networks are established during development 





Fgfr1b mutant mice (Partanen et al., 1998) were from Juha Partanen. Fgfr2b mutant mice (Fox et 
al., 2007), Fgfr2flox/flox mice (Yu et al. 2003; Umemori et al., 2004), Fgfr1flox/flox mice (Hoch and 
Soriano, 2006) and Actin-CreER mice (Guo et al., 2002; Umemori et al., 2004) were described 
previously. All mice were on a C57BL/6 background, except Fgfr1b-/- mice, which were on a 
mixed 129sv/CD-1 background. WT mice used were either C57BL/6 or ICR/CD-1. All animal 
care and use was in accordance with the institutional guidelines and approved by the Institutional 
Animal Care and Use Committees at Boston Children’s Hospital and University of Michigan. 
 
Neuronal culture. 
For FGF responsiveness assays, hippocampi were dissected from P0 pups or E18-E19 embryos, 
dissociated with 0.5% Trypsin, and grown in culture media [B27 (Gibco), 2 mM L-glutamine, 1x 
Penicillin-Streptomycin in Neurobasal (Gibco)] at a density of 36,000 cells/poly-D-lysine-coated 





P8 animals were sacrificed by decapitation (Figs 1-2) or perfusion with 4%PFA (Fig. 3). Brains 
were fixed in 4% PFA overnight. 20 μm sagittal sections were cryosectioned. Cultured neurons 
were fixed with 100% methanol, -20°C for 5 minutes. Antibodies and dilutions: VGLUT1 
(1:4000, Millipore), VGAT (1:4000, Synaptic Systems), Py (1:25, gift from M. Webb and P.L. 
Woodhams). Mounting media: glycerol with p-phenylenediamine or n-propyl gallate.  
 
Image acquisition and analysis. 
12-bit images were acquired with epifluorescence microscopes (Olympus) using 20x and 40x 
lenses with F-View II CCD (Soft Imaging System) and XM10 (Olympus) cameras at 1,376 x 
1,032 pixels resolution. Section data were analyzed using MetaMorph software. For each image, 
a threshold was chosen to exclude signal from background, based on intensity of the fimbria, a 
myelinated tract of axons exiting CA3 medially. For analysis of VGLUT1 or VGAT puncta on 
Py-positive dendrites, images were merged using ImageJ and Adobe Photoshop in 16-bit, and 
masks were drawn in Adobe Photoshop over Py-positive dendrites. Image thresholds were 
chosen to subtract background staining and separate each punctum. The threshold was then 
subtracted from the intensity measurement. Dendritic lengths were measured manually by tracing 
the length in MetaMorph. The statistical tests performed were two-tailed Student’s t-test. All 




Excitatory presynaptic differentiation is impaired in Fgfr2b and Fgfr1b mutant mice 
 
I first sought to identify the FGF receptors (FGFRs) involved in presynaptic 
differentiation by investigating whether knockout (KO) mice of candidate FGFRs show similar 
synaptic deficits observed in Fgf22-KO or Fgf7-KO mice. I focused on FGFR2b and FGFR1b 
because in mitogenesis assays with FGFR-expressing BaF3 cells, FGF22 activates FGFR2b and 
FGFR1b, and FGF7 activates FGFR2b (Zhang et al., 2006). Fgfr2 and Fgfr1b are expressed in 
excitatory neurons (Terauchi et al., 2010, Beer et al., 2000) and inhibitory interneurons in the 
hippocampus (Figure 2.1). To investigate excitatory presynaptic differentiation in mice lacking 
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Fgfr1bFgfr2 VgatVglut1
Figure 2.1. Expression of Fgfr2 and Fgfr1b in CA3 interneurons. Interneurons were 
isolated using fluorescence-activated cell sorting from the CA3 area dissected from P14 
Vgat-Venus mice (Wang et al., 2009), followed by mRNA isolation and cDNA synthesis. 
PCR amplification using specific primers demonstrates the presence of Fgfr2, Fgfr1b, and 
Slc32a1 (Vgat) transcripts, but not Slc17a7 (Vglut1) transcripts, in the CA3 interneurons.
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Fgfr2b or Fgfr1b, I stained brain sections for vesicular glutamate transporter 1 (VGLUT1), a 
marker of excitatory synaptic vesicles that cluster at nerve terminals as excitatory synapses 
develop (Figure 2.2). (This work was done together with Cameron Strong.) Fgfr2b-/- mice (Fig. 
1A) are not viable postnatally due to lung agenesis, while Fgfr2b+/- animals, though viable, have 
developmental defects such as stunted seminal vesicle development (Kuslak et al., 2007) and 
hypoplastic submandibular glands (Jaskoll et al., 2005). Hence, I investigated whether Fgfr2b 
haploinsufficiency affects excitatory presynaptic differentiation. I focused our analysis in the 
CA3 of the hippocampus, because Fgf22-KO mice show specific defects in excitatory 
presynaptic differentiation in the CA3 (Terauchi et al., 2010). I found that Fgfr2b+/- mice have 
decreased intensity of VGLUT1 immunoreactivity in the stratum radiatum (SR) and stratum 
lucidum (SL) of hippocampal CA3 at postnatal day 8 (P8), an early stage of synapse formation 
(Figure 2.2 B,C). Further analysis revealed that VGLUT1 puncta are smaller and sparser in 
Fgfr2b+/- mice compared to wild-type (WT) littermate (Figure 2.2 D). I next investigated 
Fgfr1b-/- mice (Figure 2.2 E) for excitatory presynaptic differentiation. I found that VGLUT1 
intensity is decreased both in the SL and SR layers of the hippocampal CA3 (Figure 2.2 F, G) 
and that VGLUT1 puncta are smaller and sparser in Fgfr1b-/- animals (Figure  2.2 H). I did not 
observe appreciable changes in postsynaptic differentiation, assessed by PSD95 immunostaining 
(an excitatory postsynaptic marker), in either Fgfr2b+/- or Fgfr1b-/- mice (Figure 2.3). 
Furthermore, VGLUT1 immunostaining in lateral septal nuclei does not perceptibly change in 
Fgfr mutant mice, suggesting that loss of Fgfr2b or Fgfr1b is not globally decreasing VGLUT1 
levels (Figure 2.4). These data suggest that both FGFR2b and FGFR1b are involved in excitatory 
presynaptic differentiation in the hippocampal CA3. To determine whether FGFR2b and 
FGFR1b compensate for each other's function for excitatory presynaptic differentiation, I 
investigated the effect of Fgfr1b inactivation on an Fgfr2b+/- background. I found that Fgfr2b+/-
Fgfr1b+/- (double heterozygotes) do not augment the loss of VGLUT1 staining in Fgfr2b+/- 
mice (Figure 2.2 I, J), suggesting that there is no apparent redundancy between FGFR2b and 






Figure 2.2. (Following page) Loss of Fgfr2b or Fgfr1b results in decreased excitatory 
presynaptic differentiation in hippocampal CA3 in vivo. 
(A) Schematic of Fgfr2b isoform-specific deletion: stop codon introduced into Fgfr2 exon 8 
leads to loss of Fgfr2b, but not -c splice isoforms. 
(B-D) Decreased excitatory presynaptic differentiation (VGLUT1 immunostaining) in 
hippocampal CA3 of Fgfr2b+/- mice compared to WT at P8. (B) Representative images. SL: 
stratum lucidum, SR: stratum radiatum. (C) Quantification of VGLUT1 intensity, normalized to 
WT littermates. (D) VGLUT1 puncta size and density in SL. (n=[sections, animals] 77, 5 
Fgfr2b+/-; 55, 3 WT)
(E) Schematic of Fgfr1b isoform-specific deletion: stop codon introduced into Fgfr1 exon 6 
leads to loss of FGFR1b, but not -c splice isoforms.
(F-H) Decreased excitatory presynaptic differentiation (VGLUT1 immunostaining) in 
hippocampal CA3 of Fgfr1b-/- mice compared to WT at P8. (F) Representative images. (G) 
Quantification of VGLUT1 intensity, normalized to WT littermates. (H) VGLUT1 puncta size and 
density in SL. (n=[sections, animals] 76, 7 Fgfr1b-/-; 87, 7 WT)
(I-J) Loss of one copy of Fgfr1b does not exacerbate excitatory presynaptic defects in Fgfr2b+/- 
mice. (I) Representative images. (J) VGLUT1 intensity in SR, relative to WT littermates. 
(n=[sections, animals] 15, 5 Fgfr2b+/-Fgfr1b+/-; 17, 5 Fgfr2b+/-; 20, 5 Fgfr1b+/-; 24, 6 WT)
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Figure 2.3. Postsynaptic differentiation is not affected by Fgfr deletion. 
(A) Representative images showing that Fgfr2b+/- mice at P8 do not exhibit changes in the 
clustering of PSD-95, a postsynaptic scaffolding protein at excitatory synapses, despite a 
decrease in VGLUT1 signal. (B) Representative images showing that Fgfr1b-/- mice at P8 
do not exhibit changes in PSD-95 clustering, despite decreased VGLUT1 signal. 
(C) Representative images showing that Fgfr2b+/- mice do not exhibit changes in the 
clustering of Gephyrin, a postsynaptic scaffolding protein at inhibitory synapses, despite 













































Figure 2.4. Presynaptic differentiation is not impaired in lateral septal nuclei of 
Fgfr-KO mice. 
(A-B) Fgfr2b+/- mice at P8 have no change in the VGLUT1 staining intensity in the lateral 
septal nucleus: (A) representative images, (B) quantification of intensity normalized to 
WT littermates. (C-D) Fgfr1b-/- mice at P8 have no change in the VGLUT1 staining 
intensity in the lateral septal nucleus: (C) representative images, (D) quantification of 
intensity normalized to WT littermates. (E-F) Fgfr2b+/- mice at P8 have no change in the 
VGAT staining intensity in the lateral septal nucleus: (E) representative images, 
(F) quantification of intensity normalized to WT littermates. Data represents mean ± 
s.e.m.  Scale bars, 15 µm.
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Inhibitory presynaptic differentiation is impaired in Fgfr2b but not Fgfr1b mutants 
 
I next investigated inhibitory presynaptic differentiation in Fgfr2b+/- and Fgfr1b-/- mice 
by analyzing vesicular GABA transporter (VGAT) immunostaining to detect the clustering of 
inhibitory synaptic vesicles (Figure 2.5). (This work was done together with Cameron Strong.) I 
found that Fgfr2b+/- mice have decreased VGAT intensity in SL and SR of hippocampal CA3 at 
P8 (Figure 2.5 A, B), resembling inhibitory presynaptic defects in Fgf7-KO mice (Terauchi et 
al., 2010). Further analysis showed that VGAT puncta in Fgfr2b+/- mice are smaller and sparser 
compared to WT littermates in SL (Figure 2.5 C). In contrast, Fgfr1b-/- animals do not have 
defects in inhibitory presynaptic differentiation measured by VGAT intensity, or puncta size or 
density (Figure 2.5 D-F). Even on an Fgfr2b+/- background, which has quantitatively lower 
levels of FGFR-mediated signaling, additional loss of a copy of Fgfr1b (double heterozygotes) 
does not change the level of inhibitory presynaptic defects relative to Fgfr2b+/- (Figure 2.5 G, 
H). This suggests that synapse formation is not simply regulated by the levels of FGFR 
signaling, but rather FGFR2b specifically is required for inhibitory presynaptic differentiation. I 
did not observe appreciable changes in Gephyrin immunostaining (an inhibitory postsynaptic 
marker) in Fgfr2b+/- mice (Figure 2.3). VGAT immunostaining in lateral septal nuclei does not 
perceptibly change in Fgfr2b+/- mice (Figure 2.4). These results suggest that FGFR2b, but not 
FGFR1b, contributes to inhibitory presynaptic differentiation in hippocampal CA3.  
 
FGFRs are required during the postnatal stage of presynaptic differentiation in vivo 
 
FGFR2 and FGFR1 also regulate embryonic neuronal development, including neuronal 
precursor specification and proliferation (Paek et al., 2009; Gutin et al., 2006; Stevens et al., 
2010b). To exclude the influence of embryonic events to presynaptic defects in Fgfr2b+/- and 
Fgfr1b-/- mice, we utilized conditional Fgfr-KO mice and asked whether the receptors are 
necessary during the postnatal synaptogenic stage. (This work was done by Dr. Akiko Terauchi.) 
Fgfr2 or Fgfr1 was selectively deleted in a temporally controlled manner by crossing mice 
possessing tamoxifen-inducible Cre (CreER) under the Actin promoter (Guo et al., 2002) with 
mice with a conditional allele of Fgfr2 (Fgfr2flox) (Figure 2.6 A; Yu et al., 2003) or Fgfr1 
(Fgfr1flox) (Figure 2.6 B; Hoch and Soriano, 2006). Tamoxifen injection (100 µg) efficiently 
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Figure 2-5. (Following page)  Loss of Fgfr2b, but not Fgfr1b, results in decreased 
inhibitory presynaptic differentiation in hippocampal CA3 in vivo.
(A-C) Decreased inhibitory presynaptic differentiation (VGAT immunostaining) in CA3 of 
Fgfr2b+/- mice compared to WT at P8. (A) Representative images. (B) Quantification of VGAT 
intensity, normalized to WT littermates. (C) VGAT puncta size and density in SL. (n=[sections, 
animals] 77, 5 Fgfr2b+/-; 52, 3 WT)
(D-F) No change in inhibitory presynaptic differentiation (VGAT immunostaining) in 
hippocampal CA3 of Fgfr1b-/- mice compared to WT at P8. (D) Representative images. (E) 
Quantification of VGAT intensity, normalized to WT littermates. (F) VGAT size and density in 
SL. (n=[sections, animals] 71, 6 Fgfr1b-/-; 71, 6 WT)
(G-H) Loss of one copy of Fgfr1b does not exacerbate inhibitory presynaptic defects in 
Fgfr2b+/- mice. (G) Representative images. (H) VGAT intensity, relative to WT littermates. 
(n=[sections, animals] 15, 5 Fgfr2b+/-Fgfr1b+/-; 14, 5 Fgfr2b+/-; 12, 4 WT)















































































































Figure 2.6. (Following page) Temporally restricted loss of Fgfr2 and Fgfr1 during the 
synaptogenic period results in deficiencies in presynaptic differentiation in 
hippocampal CA3 in vivo. 
(A-B) Conditional Fgfr-knockout strategy: Mice carrying Actin-promoter-driven CreER were 
crossed with Fgfr2flox/flox or Fgfr1flox/flox mice. Tamoxifen injection at P0 induced Fgfr 
deletion (Fgfr2-KO and Ffgr1-KO, respectively) postnatally. Controls: Cre-negative, 
tamoxifen-injected littermates.
(C-E) Decreased excitatory presynaptic differentiation (VGLUT1 immunostaining) in CA3 of 
Fgfr2-KO and Fgfr1-KO at P8. (C) Representative images. (D) VGLUT1 intensity in SL, 
normalized to littermate controls. (E) VGLUT1 puncta size and density in SL. (n=[sections, 
animals] 28, 4 Fgfr2-KO; 21, 3 Fgfr2-Control; 24, 4 Fgfr1-KO; 24, 4 Fgfr1-Control)
(F-H) Decreased inhibitory presynaptic differentiation (VGAT immunostaining) in CA3 of 
Fgfr2-KO but not Fgfr1-KO at P8. (F) Representative images. (G) VGAT intensity in SL, 
normalized to littermate controls. (H) VGAT puncta size and density in SL. (n=[sections, 
animals] 34, 5 Fgfr2-KO; 35, 5 Fgfr2-Control; 18, 3 Fgfr1-KO; 18, 3 Fgfr1-Control)
Scale bars, 15 µm.
32
Fgfr2











































































































































induces CreER-mediated excision of floxed genes (Figure 2.7). Tamoxifen was injected into 
Actin-CreER::Fgfr2flox/flox or Actin-CreER::Fgfr1flox/flox pups at P0, resulting in Fgfr2-KO or 
Fgfr1-KO animals, in which both b and c receptor splice forms are deleted postnatally. Both 
Fgfr2-KO and Fgfr1-KO animals have decreased excitatory presynaptic differentiation in 
hippocampal CA3 at P8, as measured by VGLUT1 immunoreactivity, compared to their 
respective controls (Figure 2.6 C-E). VGLUT1 puncta are smaller in Fgfr2-KO animals, and both 
smaller and sparser in Fgfr1-KO animals (Figure 2.6 E). On the other hand, only Fgfr2-KO, but 
not Fgfr1-KO animals have decreased inhibitory presynaptic differentiation at P8, measured by 
VGAT immunoreactivity (Figure 2.6 F-H). In Fgfr2-KO, but not Fgfr1-KO animals, VGAT 
puncta are smaller and sparser (Figure 2.6 H). Both the excitatory and inhibitory presynaptic 
defects in Fgfr-KO mice persisted at P14 (Figure 2.8), the end of initial synapse formation in the 
hippocampus, suggesting that Fgfr inactivation does not simply delay presynaptic differentiation. 
Thus, during the postnatal synaptogenic stage, excitatory presynaptic differentiation in 
hippocampal CA3 requires both FGFR2 and FGFR1, and inhibitory presynaptic differentiation 
requires FGFR2 but not FGFR1.  
 
FGF22 requires FGFR2b and FGFR1b to induce excitatory presynaptic differentiation 
 
I have shown that FGFR2b and FGFR1b are necessary for excitatory presynaptic 
differentiation in vivo (Figures 2.2 and 2.6). I next tested whether FGFR2b and FGFR1b are 
receptors for FGF22 to organize excitatory presynaptic terminals in neurons. I cultured 
hippocampal neurons from Fgfr2b-/- embryos, Fgfr1b-/- P0 pups, and their respective WT 
littermates, treated with FGF22 on day two in vitro (DIV2), and examined response to FGF22 by 
VGLUT1 staining on DIV14 (Figure 2.9 A). FGF22 acts on inputs synapsing onto CA3 
pyramidal neurons (Terauchi et al., 2010), so I focused my analysis on synapses forming onto 
CA3 pyramidal neurons. CA3 neurons were identified by staining with the antibody Py 
(Woodhams et al., 1989), and VGLUT1 puncta contacting Py-positive dendrites were quantified. 
WT neurons respond to FGF22 with a two-fold increase in VGLUT1 signal along CA3 
dendrites; however, Fgfr2b-/- neurons do not respond to FGF22 (Figure 2.9 B, C). Closer 
analysis revealed that the response to FGF22 in WT, but not Fgfr2b-/- neurons comprises 

































Figure 2.7. Demonstration of efficient Cre-mediated excision of floxed genes in vivo 
and in vitro. (A) Mice carrying the tamoxifen-sensitive Cre (CreER) under a CAG promoter 
(human CMV virus enhancer and chicken β-actin promoter) (Actin-CreER; Guo et al., 2002) 
were crossed with mice carrying EYFP preceded by a loxP-flanked STOP sequence under 
a Thy1 promoter (Thy1-STOP-YFP; Buffelli et al., 2003). Tamoxifen was injected at P0, 
activating CreER and leading to expression of EYFP in neurons, with an efficiency of >85%. 
Representative image of CA1 pyramidal neurons. SO – stratum oriens; SP – stratum pyra-
midale; SR – stratum radiatum. Scale bar, 100 µm. (B) A Cre expression plasmid was 
co-transfected with a loxP-STOP-loxP-YFP plasmid and an mCherry plasmid into HEK cells 
using calcium-phosphate transfection method. >90% of transfected cells (red) showed 




























Figure 2.8. Presynaptic defects persist in the hippocampus of Fgfr-KO mice at P14. 
(A) Representative images showing that defects in VGLUT1 clustering persist at P14 in 
Fgfr2-KO mice. (B) Representative images showing that defects in VGLUT1 clustering 
persist at P14 in Fgfr1-KO mice. (C) Representative images showing that defects in VGAT 
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Figure 2.9. Fgfr2b-/- or Fgfr1b-/- neurons do not respond to FGF22 in culture.
(A) Experimental scheme. Hippocampal neurons were cultured from Fgfr2b-/- embryos or 
Fgfr1b-/- pups and WT littermates. 2 nM FGF22 was applied on DIV2. Neurons were stained at 
DIV14 for VGLUT1 and Py, a marker of CA3 pyramidal neurons. VGLUT1 puncta contacting 
CA3 dendrites were analyzed.
(B-E) Fgfr2b-/- neurons do not respond to FGF22. (B) Representative images of VGLUT1 
puncta (green) contacting CA3 dendrites (red). Contacting puncta are indicated in WT condition 
with arrowheads. (C) Quantification of FGF22 responsiveness. For each genotype, total 
intensity of VGLUT1 on CA3 dendrite of FGF22-treated neurons was divided by that of 
untreated neurons. (D) VGLUT1 density and (E) size along CA3 dendrites. (n=[neurons, 
experiments] 25, 3 WT; 30, 3 WT+FGF22; 34, 3 Fgfr2b-/-; 30, 3 Fgfr2b-/-+FGF22)
(F-I) Fgfr1b-/- neurons do not respond to FGF22. (F) Representative images. (G) VGLUT1 
response to FGF22, quantified as in (C). (H) VGLUT1 density and (I) size along CA3 dendrites. 
(n=[neurons, experiments] 45, 6 WT; 45-, 6 WT+FGF22; 44, 6 Fgfr1b-/-; 44, 6 Fgfr1b-/-+FGF22)
In scatter plots, each dot represents average value from an individual neuron analyzed. Scale 
bar, 5 µm.
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size (Figure 2.9 E). Fgfr1b-/- neurons also do not respond to FGF22 (Figure 2.9 F-I): there was 
no FGF22-induced increase in density (Figure 2.9 H) or size (Figure 2.9 I) of VGLUT1 puncta. 
In control experiments examining neuronal cell fate, dendritic morphology of CA3 neurons and 
their excitatory postsynaptic differentiation, I found no apparent differences between WT 
neurons, Fgfr2b-/- neurons, or Fgfr1b-/- neurons in the presence or absence of FGF22 (Figures 
2.10 and 2.11), suggesting that FGFR2b and FGFR1b primarily affect presynaptic 
differentiation. Together, these results indicate that both FGFR2b and FGFR1b are required for 
FGF22-dependent induction of excitatory presynaptic differentiation. 
 
FGFRs are necessary during the synaptogenic stage for FGF22-dependent excitatory 
presynaptic differentiation  
 
To determine whether FGFRs are required specifically during the synaptogenic stage in 
vitro, I temporally restricted Fgfr2 and Fgfr1 deletion. Hippocampal neurons were cultured from 
Actin-CreER::Fgfr2flox/flox or Actin-CreER::Fgfr1flox/flox mice. On DIV1, 10 nM 4-
hydroxytamoxifen (4-OHT) was applied to cultures, generating Fgfr2-KO or Fgfr1-KO neurons. 
We found this dose efficiently inactivates Fgfrs (Figure 2.12). FGF22 was applied on DIV2, and 
the neurons were assessed on DIV14 for VGLUT1 clustering on Py-positive dendrites (Figure 
2.13 A). Control neurons respond to FGF22 with a three-fold increase in VGLUT1 
immunoreactivity along CA3 dendrites, while Fgfr2-KO neurons do not respond (Figure 2.13 
B,C). There are no FGF22 responses in VGLUT1 puncta density (Figure 2.13 D) and size 
(Figure 2.13 E) in Fgfr2-KO neurons. Conversely, Fgfr1-KO neurons have an attenuated, but 
still present response to FGF22 (Figure 2.13 F, G). Where control neurons respond to FGF22 
with a three-fold increase in VGLUT1 signal along CA3 dendrites, Fgfr1-KO neurons respond 
with a two-fold increase (Figure 2.13 G), with significant increases in VGLUT1 density (Figure 
2.13 H) and size (Figure 2.13 I). Therefore, I conclude that FGFR2 is required during the 
synaptogenic stage to respond to FGF22 to induce excitatory presynaptic differentiation, while 
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Figure 2.10. Cell numbers and fates of cultured hippocampal neurons in vitro. 
Cultured hippocampal neurons from WT and Fgfr2b-/- mice (A), WT and Fgfr1b-/- mice (B), 
Control and Fgfr2-KO mice (C), and Control and Fgfr1-KO mice (D) were stained with DAPI 
to count total cell number, NeuN (1:500, Millipore) to detect mature neurons, and GAD65/67 
(1:500, Millipore) to detect inhibitory neurons. Cells were counted from 15 fields (A, B) or 12 
fields (C, D) per genotype, each from 3 experiments. No significant changes in the number 
of total cells, total neurons, or inhibitory neurons were detected between Fgfr2b-/-, Fgfr1b-/-, 
or Fgfr2-KO cultures and their respective controls (A, B, C). A significant (p<0.01) decrease 
in the total number of cells, but not total number of neurons or inhibitory neurons, in 
Fgfr1-KO cultures compared to control (D). Cell counts for each set of experiments were 
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Figure 2.11. Loss of Fgfr2b or Fgfr1b as well as application of FGF22 do not lead to 
apparent changes in dendritic morphology or excitatory postsynaptic differentiation 
of CA3 neurons. (A) Representative images of WT and Fgfr2b-/- neurons with and without 
FGF22 treatment exhibit similar dendritic morphology, as observed by Py staining in culture. 
(B) WT and Fgfr2b-/- neurons with and without FGF22 treatment do not demonstrate 
changes in PSD95 (1:500, NeuroMab) staining on Py-positive dendrites. (C) Representative 
images of WT and Fgfr1b-/- neurons with and without FGF22 treatment exhibit similar 
dendritic morphology, as observed by Py staining in culture. (D) WT and Fgfr1b-/- neurons 
with and without FGF22 treatment do not demonstrate changes in PSD95 staining on 
Py-positive dendrites. Scale bars in (A, C) are 50 µm. Scale bars in (B, D) are 5 µm.
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1: Actin-CreER::Fgfr1flox/flox hippocampal neurons
2: Actin-CreER::Fgfr1flox/flox hippocampal neurons + 10 nM 4-OHT (KO)


























Figure 2.12. Efficient inactivation of floxed Fgfr genes by 4-OH tamoxifen treatment in 
vitro. Hippocampal neuron cultures were prepared from Actin-CreER::Fgfr1flox/flox and Fgfr1flox/flox 
(no Cre) littermates. Cultures were treated with 10 nM 4-OH tamoxifen (4-OHT). (A) mRNA 
was isolated and cDNA synthesized from Actin-CreER::Fgfr1flox/flox not treated with 4-OHT (no 
4-OHT control), Actin-CreER::Fgfr1flox/flox treated with 10 nM 4-OHT at DIV1 (KO), and 
Fgfr1flox/flox treated with 10 nM 4-OHT (no Cre control). RT-PCR using primers specific for 
Fgfr1b revealed a stark decrease in Fgfr1b transcripts in KO neurons. (B) Quantification of 
Fgfr1b mRNA levels in KO neurons relative to no 4-OHT and no Cre controls. (C) 
Quantification of FGFR1 protein levels. KO neurons had a pronounced decrease in the amount 
of FGFR1 protein compared to no 4-OHT and no Cre controls. Protein lysate was prepared 
from cultured hippocampal neurons using 50 mM Tris-HCl, 150 mM NaCl, 1% NP-40 lysis 
buffer supplemented with Protease Inhibitor Cocktail (Roche). Western blot for FGFR1 was 
performed with the anti-FGFR1 antibody (1:100, Sigma, Cat# F5421). The intensity of FGFR1 
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Figure 2.13. Fgfr2-KO neurons, in which receptor deletion is temporally restricted to 
synaptogenic period, do not respond to FGF22 in culture.
(A) Experimental scheme. Hippocampal neurons were cultured from Actin-CreER::Fgfr2flox/flox 
or Actin-CreER::Fgfr1flox/flox pups and littermate controls lacking CreER. 10 nM 4-OHT was 
applied at DIV1 to induce receptor deletion, and FGF22 was applied at DIV2. Neurons were 
stained at DIV14 for VGLUT1 and Py. VGLUT1 puncta contacting CA3 dendrites were 
analyzed.
(B-E) Fgfr2-KO neurons do not respond to FGF22. (B) Representative images of VGLUT1 
puncta (green) contacting CA3 dendrites (red). (C) VGLUT1 response to FGF22, quantified as 
in Fig. 4C. (D) VGLUT1 density and (E) size along CA3 dendrites. (n=[neurons, experiments] 
25, 3 Control; 25, 3 Control+FGF22; 29, 3 Fgfr2-KO; 29, 3 Fgfr2-KO+FGF22).
(F-I) Fgfr1-KO neurons partially respond to FGF22. (F) Representative images. (G) VGLUT1 
response to FGF22, quantified as in Fig. 4C. (H) VGLUT1 density and (I) size along CA3 
dendrites. (n=[neurons, experiments] 35, 4 Control; 35, 4 Control+FGF22; 40, 4 Fgfr1-KO; 35, 4 
Fgfr1-KO+FGF22)
Scale bars, 5 µm.
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FGF7 requires FGFR2b but not FGFR1b to induce inhibitory presynaptic differentiation 
 
Fgfr2b+/- mice exhibit defects in inhibitory presynaptic differentiation (Figures 2.5 and 
2.6), similar to Fgf7-KO mice (Terauchi et al., 2010). I next tested whether FGFR2b is a receptor 
for FGF7 to organize inhibitory presynaptic terminals. Hippocampal neurons from Fgfr2b-/- 
embryos, Fgfr1b-/- P0 pups, and WT littermates were treated on DIV2 with FGF7, and assessed 
at DIV14 for VGAT clustering on Py-positive dendrites (Figure 2.14 A). WT neurons respond to 
FGF7 with a two-fold increase in VGAT staining along CA3 dendrites, while Fgfr2b-/- neurons 
do not respond (Figure 2.14 B-E). In Fgfr2b-/- neurons, FGF7 does not increase VGAT puncta 
density (Figure 2.14 D) or size (Figure 2.14 E). Meanwhile, Fgfr1b-/- neurons respond equally to 
WT controls with a two-fold increase in VGAT intensity along CA3 dendrites (Figure 2.14 F, G) 
as well as increases in VGAT density (Figure 2.14 H) and size (Figure 2.14 I). I observed no 
apparent changes in dendritic morphology of CA3 neurons and inhibitory postsynaptic 
differentiation on CA3 dendrites between WT cultures, Fgfr2b-/- cultures, or Fgfr1b-/- cultures, 
with or without FGF7 (Figure 2.15). Together, these data suggest that FGFR2b, but not FGFR1b, 
is required for FGF7-induced inhibitory presynaptic differentiation.  
 
FGFR2 is necessary during the synaptogenic stage in FGF7-dependent inhibitory 
presynaptic differentiation 
 
To confirm that FGFR2 is required during the synaptogenic stage to respond to FGF7, we 
temporally restricted Fgfr2 deletion. Actin-CreER::Fgfr2flox/flox hippocampal cultures were treated 
with 10 nM 4-OHT on DIV1 to induce receptor deletion, FGF7 on DIV2, and assessed on DIV14 
for VGAT clustering along Py-positive dendrites (Figure 2.16 A). In response to FGF7, control 
neurons have a three-fold increase in VGAT intensity along CA3 dendrites, while Fgfr2-KO 
neurons do not respond (Figure 2.16 B, C). Where control neurons respond to FGF7 with 
increases in VGAT puncta density (Figure 2.16 D) and size (Figure 2.16 E), Fgfr2-KO neurons 
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Figure 2.14.  Fgfr2b-/- neurons do not, but Fgfr1b-/- neurons do respond to FGF7 in 
culture.
(A) Experimental scheme. Hippocampal neurons were cultured from Fgfr2b-/- embryos or 
Fgfr1b-/- pups and WT littermates. 2 nM FGF7 was applied on DIV2. Neurons were stained at 
DIV14 for VGAT and Py. VGAT puncta contacting CA3 dendrites were analyzed.
(B-E) Fgfr2b-/- neurons do not respond to FGF7. (B) Representative images of VGAT puncta 
(green) contacting CA3 dendrites (red). (C) Quantification of FGF7 responsiveness. For each 
genotype, total intensity of VGAT on CA3 dendrite of FGF7-treated neurons was divided by that 
of untreated neurons. (D) VGAT density and (E) size along CA3 dendrites. (n=[neurons, 
experiments] 30, 3 WT; 38, 3 WT+FGF7; 25, 3 Fgfr2b-/-; 25, 3 Fgfr2b-/-+FGF7) 
(F-I) Fgfr1b-/- neurons respond to FGF7. (F) Representative images. (G) VGAT response to 
FGF7, quantified as in (C). (H) VGAT density and (I) size along CA3 dendrites. (n=[neurons, 
experiments]   23, 3 WT; 26, 3 WT+FGF7; 24, 3 Fgfr1b-/-; 23, 3 Fgfr1b-/-+FGF7)
Scale bars, 5 µm.
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Figure 2.15. Loss of FGFR2b or FGFR1b as well as application of FGF7 do not lead to 
apparent changes in dendritic morphology or inhibitory postsynaptic differentiation 
of CA3 neurons. (A) Representative images of WT and Fgfr2b-/- neurons with and without 
FGF7 treatment exhibit similar dendritic morphology, as observed by Py staining in culture. 
(B) WT and Fgfr2b-/- neurons with and without FGF7 treatment do not demonstrate 
changes in Gephyrin (1:50, Synaptic Systems) staining on Py-positive dendrites. (C) 
Representative images of WT and Fgfr1b-/- neurons with and without FGF7 treatment 
exhibit similar dendritic morphology, as observed by Py staining in culture. (D) WT and 
Fgfr1b-/- neurons with and without FGF7 treatment do not demonstrate changes in 
Gephyrin staining on Py-positive dendrites. Scale bars in (A, C) are 50 µm. Scale bars in 
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Figure 2.16. Fgfr2-KO neurons, in which receptor deletion is temporally restricted to 
synaptogenic period, do not respond to FGF7 in culture.
(A) Experimental scheme. Hippocampal neurons were cultured from Actin-CreER::Fgfr2flox/-
flox pups and littermate controls lacking CreER. 4-OHT was applied at DIV1, and FGF7 was 
applied at DIV2. Neurons were stained for VGAT and Py at DIV14. VGAT puncta contacting 
CA3 dendrites were analyzed.
(B-E) Fgfr2-KO neurons do not respond to FGF7. (B) Representative images of VGAT puncta 
(green) contacting CA3 dendrites (red). (C) VGAT response to FGF7, quantified as in Fig. 
6C. (D) VGAT density and (E) size along CA3 dendrites. (n= [neurons, experiments] 30, 3 
Control; 30, 3 Control+FGF7; 29, 3 Fgfr2-KO; 29, 3 Fgfr2-KO+FGF7). 




In this chapter, I demonstrated, using both in vivo and in vitro evidence, that differential 
use of FGFRs by FGF22 and FGF7 contributes to their presynaptic effects on excitatory and 
inhibitory synapses in the CA3 region of the hippocampus. 
 
The coordinated development of excitatory and inhibitory synapses in the hippocampal 
CA3 is guided by FGF22 and FGF7 with remarkable specificity. After the fate of excitatory and 
inhibitory neurons has been specified and as their axons approach CA3, FGF22 and FGF7 are 
secreted from CA3 dendrites at discrete excitatory and inhibitory postsynaptic sites, respectively, 
to promote distinct presynaptic differentiation (Terauchi et al., 2010). I found that, in addition to 
specific localization of ligand secretion, overlapping but distinct sets of FGFRs are required for 
excitatory versus inhibitory presynaptic differentiation, providing robustness to the system. 
FGF22 and FGF7 both activate FGFR2b, but we propose that FGFR1b plays an important role in 
coordinating specificity. FGF22, but not FGF7, activates FGFR1b in in vitro suspension cell 
proliferation assays (Zhang et al., 2006), and we found that in the hippocampus, FGFR1b is 
required for excitatory synapse formation in response to FGF22 (Fig. 4), but not for inhibitory 
synapse formation in response to FGF7 (Figure 2.14). Consistent with this specificity, Fgfr2b-
lacking mice have excitatory and inhibitory presynaptic deficits, and Fgfr1b-lacking mice have 
only excitatory presynaptic deficits (Figure 2.2, 2.5, and 2.6). The receptor KO mice do not 
completely lose excitatory or inhibitory presynaptic differentiation, suggesting that FGFRs 
cooperate with other synaptogenic receptors for presynaptic differentiation.  
What is the relationship between FGFR2b and FGFR1b in promoting excitatory 
presynaptic differentiation in response to FGF22? Both FGFR2b and FGFR1b appear to be 
necessary presynaptically for responsiveness to FGF22 in vitro (which I will show in Chapter 3); 
however, they do not appear to be redundant in terms of their effect on excitatory presynaptic 
differentiation (Figure 2.2). One possibility is that FGFR2b and FGFR1b form heterodimers. 
Under conditions of complete ligand absence, FGFR2 and FGFR1 can form heterodimers (Wang 
et al., 1997) and ligand can induce transphosphorylation (Bellot et al., 1991), although whether 
the native forms do so during development has not yet been demonstrated. Alternatively, they 
cooperate as independent homodimers to promote presynaptic differentiation, where FGFR2b is 
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the dominant receptor required for both excitatory and inhibitory presynaptic differentiation, 
while FGFR1b specifically modulates excitatory presynaptic differentiation in response to 
FGF22. Interestingly, FGFR1b appears to have a modulatory role in relation to FGFR2b in other 
systems. For example, FGF10, which, like FGF22, activates both FGFR2b and FGFR1b (Zhang 
et al., 2006), plays an important role in lung and submandibular gland development. In both 
systems, FGFR2b promotes glandular proliferation and elongation and induces FGFR1b 
expression at the end buds, while FGFR1b is important specifically for end bud expansion 
(Steinberg et al., 2005; Patel et al., 2008). Identification of the precise roles of FGFR1b in 
excitatory presynaptic differentiation is an important next question. 
 
Unbalanced excitation-inhibition has behavioral consequences: Fgf22-KO and Fgf7-KO 
mice have altered epileptic seizure susceptibility (Terauchi et al., 2010; Lee et al., 2012; Lee and 
Umemori, 2013). Additionally, other FGFs have also been implicated in epilepsy (Paradiso et al., 
2013). What are the behavioral, neurological, or psychiatric consequences of losing FGFR2b or 
FGFR1b signaling in humans? Dominant negative mutations and mutations leading to 
overactivation in FGFR2 and FGFR1 cause craniosynostosis syndromes, dominated by cranial 
defects, which also include seizures and intellectual disability (Agochukwu et al., 2012; Melville 
et al., 2010; Stevens et al., 2010a; Williams and Umemori, 2014). Analysis of single-nucleotide 
polymorphisms in human patients has linked mutations in FGFR2 to susceptibility to 
schizophrenia (O’Donovan et al., 2009) and bipolar disorder (Wang et al., 2012), and FGFR1 
mutations to susceptibility to depression (Gaughran et al 2006) and schizophrenia (Shi et al., 
2011). These analyses do not differentiate between the isoform-specific contributions of the 
receptors; however, all of this evidence supports the idea that FGFR signaling is crucial to proper 


















Synaptogenic FGFR Signaling 
 
The following work is in press for publication in the journal Development as: Dabrowki, A., 
Terauchi, A., Strong, C., and Umemori, H. (2015) Distinct sets of FGF receptors sculpt 
excitatory and inhibitory synaptogenesis. 
 
 
 Introduction.  
 
Compared to what is known about signaling pathways involved in postsynaptic 
development (Ebert and Greenberg, 2013; Hagenston and Bading, 2011; Mabb and Ehlers, 2010; 
Shen and Cowan, 2010; Stamatakou and Salinas, 2014; Tolias et al., 2011), less is known about 
signaling pathways guiding presynaptic differentiation. The presynaptic contribution of 
individual signaling pathways has been studied using broad inhibition or overactivation: 
PI3K/AKT (Martin-Peña et al., 2006; Cuesto et al., 2011), extracellular signal-related kinase 
(ERK)/mitogen-activated protein kinase (MAPK) (Li et al., 2002; Kushner et al., 2005; Nakata et 
al., 2005; Wairkar et al., 2009; Giachello et al., 2010), and PLCγ (Yoshida et al., 2009) are all 
proposed to be involved in presynaptic development. The contributions of different signaling 
pathways may reflect the molecular complexity of synapse formation, underscoring how crucial 
it is to understand the signaling pathways downstream of specific synaptogenic receptors to tease 
apart this complexity. 
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 In the previous chapter, I showed that differential sets of FGF receptors are required for 
excitatory and inhibitory presynaptic differentiation in the hippocampal CA3. Specifically, I 
demonstrated that FGF22 requires FGFR2b and FGFR1b for excitatory presynaptic 
differentiation, while FGF7 requires FGFR2b for inhibitory presynaptic differentiation. In this 
chapter, I will address where the receptors function, and what the downstream intracellular 
signaling pathways required for presynaptic differentiation are. Where do the receptors act? 
What are the signaling pathways involved? Using conditional knockout mice and a series of in 
vitro experiments, I showed that FGFRs are required in the presynaptic neuron through a 





Fgfr2flox/flox mice (Yu et al. 2003; Umemori et al., 2004) and Fgfr1flox/flox mice (Hoch and Soriano, 
2006) were described previously. All mice were on a C57BL/6 background. WT mice used were 
either C57BL/6 or ICR/CD-1. All animal care and use was in accordance with the institutional 
guidelines and approved by the Institutional Animal Care and Use Committees at Boston 
Children’s Hospital and University of Michigan. 
 
Neuronal culture. 
For DGC and interneuron transfections, dissociated DG and CA3 cells were plated at a density of 
50,000 cells/coverslip, and culture media was supplemented with 5 mM KCl. 1 μg of plasmids 
per coverslip were transfected using CalPhos Transfection Kit (Clontech). FGF22 (R&D) and 
FGF7 (PeproTech) were dissolved to 3 nM for Synaptophysin-YFP experiments. 
 
Plasmids. 
To generate Fgfr1b-GFP, the coding region of Fgfr1b cDNA was PCR amplified from neonatal 
mouse skin cDNA and fused with GFP in pEGFP-N1 (Clontech). To generate Fgfr2b-EGFP, the 
coding region of Fgfr2b cDNA from IMAGE clone 5349249 (ATCC) was inserted into 
pcDNA3.1 with EGFP cDNA.  
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Fgfr2b mutant constructs were generated using PCR amplification and insertion into the pAP-
TAG5 plasmid (GenHunter) using the following combinations of primers: 5’-
ATACTAGTCATGGGATTACCGTCC-3’ (primer-N) with 5’-
ATGGGCCCTCATGTTTTAACACTGCCG-3’ (primer-C) for WT Fgfr2b; primer-N with 5’-
ATGTCGACTTCCAGTCAAGTGGATGGCTCC-3’and 5’-
ATGTCGACCATTTGTGGTCTTTTTTTCTTCGTCTATGTTGTTG-3’ with primer-C for 
Fgfr2b-KD; primer-N with 5’-ATCTGCAGAGTCCAGCTCCTCCATGAAC-3’and 5’-
ATCTGCAGAAACCTGTCTCCGCAGGGGG-3’ with primer-C for Fgfr2b-FRS2; primer-N 
with 5’-ATGAGCTAGCCATGATGATGAG-3’and 5’-TCATGGCTAGCTCATTGGTGC-3’ 
with primer-C for Fgfr2b-PI3K; and primer-N with 5’-
ATAAGCTTTGGATCTCACCCAGCCTC-3’and 5’-
ATAAAGCTTCCTCATTGGTTGTGAGAG-3’ with primer-C for Fgfr2b-PLCγ. All PCR 
products were verified with sequencing. 
 
Immunostaining. 
Cultured neurons were fixed with 100% methanol, -20°C for 5 minutes. Antibodies and 
dilutions: GFP (1:5000, Aves), Prox1 (1:500, Millipore), Py (1:25, gift from M. Webb and P.L. 
Woodhams). Mounting media: glycerol with n-propyl gallate.  
 
Image acquisition and analysis. 
12-bit images were acquired with epifluorescence microscopes (Olympus) using 20x and 40x 
lenses with F-View II CCD (Soft Imaging System) and XM10 (Olympus) cameras at 1,376 x 
1,032 pixels resolution. Synaptophysin-YFP images were analyzed using Fiji. The entire axonal 
arbor was imaged and analyzed. Images were processed to exclude dendrites and converted to 8-
bit. For each neuron, a threshold was chosen separately to capture the dimmest punctum and 
remove diffuse background axonal staining. Masks were applied to images and puncta size and 
count were calculated in Fiji. Axon length was traced manually in Fiji. The statistical tests 







FGFR2 and FGFR1 localize and function presynaptically to respond to FGF22  
 
Since FGF22 and FGF7 are secreted from postsynaptic sites and retrogradely induce 
differentiation at presynaptic terminals, I hypothesize that FGFR2b and FGFR1b are localized 
and function presynaptically in the axon. Previous studies reported that FGFR1 and FGFR2 are 
expressed in axons, dendrites and soma of cultured hippocampal neurons (Li et al., 2002); 
however, there are no adequate antibodies against FGFR2b or FGFR1b to directly test their 
endogenous localization. Thus, I used an alternative strategy of overexpressing fluorescently-
tagged FGFR2b and FGFR1b in cultured neurons to follow their localization (Figure 3.1). 
FGFR2b-GFP and FGFR1b-GFP both localized throughout the cell including the axon, along 
which FGFRs accumulate in a punctate manner (Figure 3.1 A, B). In order to demonstrate their 
localization to presynaptic terminals within the axon, we co-transfected fluorescently-tagged 
Synaptophysin, which marks synaptic vesicles (Li and Murthy, 2001; De Paola et al., 2003; 
Umemori et al., 2004). The majority of FGFR2b-GFP colocalized with Synaptophysin-mCherry 
(Figure 3.1 C), and the majority of FGFR1b-GFP colocalized with Synaptophysin-mCherry 
(Figure 3.1 D). This indicates that FGFR2b and FGFR1b can indeed localize to axon terminals, 
consistent with a presynaptic role. 
 
I then examined whether the receptors function presynaptically. FGF22 acts on excitatory 
axon terminals contacting CA3 pyramidal neurons, including those from dentate granule cells 
(DGCs). Therefore, I first focused on FGF22-induced excitatory presynaptic differentiation 
within the axons of DGCs. Neuronal cultures prepared from DG and CA3 from Fgfr2flox/flox or 
Fgfr1flox/flox animals were sparsely co-transfected at DIV1 with Cre, to induce cell-autonomous 
receptor deletion, and synaptophysin-YFP, to visualize synaptic vesicles. Co-transfection 
efficiency was nearly 100%, and efficiency of Cre-mediated excision of floxed genes was 
estimated to be ~90% (Figure 2.7). Thus, the Fgfr was deleted in transfected, Synaptophysin-
YFP-positive cells, while untransfected cells remained WT. The transfection was very sparse to 
analyze single cells not contacting other transfected cells (Figure 3.2), ensuring a cell-




































Figure 3.1. FGFR2b and FGFR1b localize to presynaptic terminals.
WT neurons in culture were transfected with GFP-tagged Fgfr constructs. 
(A,B) FGFR2b-GFP (A) and FGFR1b-GFP (B) localize to neurofilament (NF)-positive 
axons. 
(C,D) When co-transfected with Synaptophysin-mCherry, the majority of FGFR2b-GFP 
(C) and FGFR1b-GFP (D) puncta colocalize with Synaptophysin-mCherry. 
Scale bar, 10 µm.
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Figure 3.2. Sparse transfection of Synaptophysin-YFP into hippo-
campal culture. 
A) Representative image of a transfected neuron, with punctate 
Synaptophysin-YFP fluorescent labeling (green) of the entire axonal 
arbor. DAPI (blue) reveals the presence of other untransfected cells. To 
isolate the effect of transfection for a cell-autonomous effect and 
minimize the effect of other transfected cells, sparse transfections were 
performed in experiments described in Figures 3.4, 3.6, and 3.7. The 
expression plasmid carrying Synaptophysin-YFP under the CMV 
promoter, together with experimental plasmids (such as Cre expression 
or empty vector), were transfected into neuronal cultures. Of the 
approximately 50,000 cells plated on a 12-mm coverslip (113 mm2), only 
about 50 cells were transfected per coverslip, thus there were fewer 
than 0.5 transfected cells per mm2. Only transfected neurons not 
contacting other transfected cells were analyzed, to maximize the 
possibility of cell-autonomous effects. Scale bar, 500 µm.
B) Example image of a Synaptophysin-YFP transfected astrocyte. Most 
transfected cells were neurons and not astrocytes (less than 5% of 




1993; Williams et al., 2011). Fgfr deletion did not obviously affect DGC axon length (Figure 
3.3). The neurons were treated with FGF22 at DIV2 and fixed for visualization at DIV11 (Figure 
3.4 A, B). Control DGCs (transfected with non-Cre plasmid) responded to FGF22 to induce 
Synaptophysin-YFP clustering, while both Fgfr2-deleted and Fgfr1-deleted DGCs failed to 
respond (Figure 3.4 C, D), both in terms of Synaptophysin-YFP puncta density within the axon 
(Figure 3.4 E) or size (Figure 3.4 F). These data suggest that both FGFR2 and FGFR1 are 
essential and function in the presynaptic neuron to respond to FGF22. 
 
Next, I studied the functional presynaptic requirement of FGFR2 at inhibitory synapses in 
response to FGF7. To do this, we performed a similar experiment as described above, but treated 
with FGF7 and identified transfected interneurons using GABA immunoreactivity (Figure 3.5 A, 
B). We found that control interneurons respond to FGF7 to induce Synaptophysin-YFP 
clustering both in terms of density and size, while Fgfr2-KO interneurons fail to respond (Figure 
3.5 C-F). These data suggests that Fgfr2 functions in the presynaptic interneuron to respond to 
FGF7.   
 
Because each coverslip in my experiment contained more than one Cre/Synaptophysin-
YFP transfected (i.e., Fgfr-KO) cell, I cannot completely exclude the possibility that other Fgfr-
KO cells on the coverslip indirectly affected Synaptophysin-YFP clustering in the neuron I 
examined. However, because only ~0.1% of cells were transfected (Figure 3.2), untransfected 
WT cells would likely mask the indirect effect of sparse receptor deletion. Thus, my data suggest 
that FGFRs function directly in presynaptic neurons. 
 
FGFR2b requires kinase activity, and FRS2 and PI3K binding to respond to FGF22 
 
My experiments show that FGFR2 is required in the presynaptic neuron to respond to 
FGF22. We next asked whether kinase activity is required for and which intracellular signaling 
pathways are involved in FGF22-dependent presynaptic differentiation. FGFRs belong to the 
receptor tyrosine kinase family of proteins and have an intracellular kinase domain, which 
becomes activated after ligand-induced receptor dimerization, triggering a multi-step 



















Figure 3.3. Axon length does not significantly change in Fgfr-deleted DGCs or 
interneurons. (A) Average axon length in Fgfr2-deleted or Fgfr1-deleted DGCs does not 
significantly change from control.  (B) Average axon length in Fgfr2-deleted interneurons 
does not significantly change from control. Data represents mean ± s.e.m. DGC axon 
lengths were compared using a One-way ANOVA with a post hoc Tukey’s test. Interneuron 












































































Figure 3.4.  Selective deletion of Fgfr2 or Fgfr1 in dentate granule cells eliminates 
response to FGF22. 
(A) Experimental scheme. DG and CA3 neurons were cultured from Fgfr2flox/flox or 
Fgfr1flox/flox pups. At DIV1, neurons were sparsely transfected with Cre to induce Fgfr deletion 
(Fgfr2-deleted, or Fgfr1-deleted) and with Synaptophysin-YFP to label synaptic vesicles. 
Control transfections consisted of Synaptophysin-YFP and empty vector without Cre. Neurons 
were treated with 3 nM FGF22 on DIV2. At DIV11, neurons were stained for Prox1 to identify 
DGCs. Synaptophysin-YFP puncta in axons from discretely transfected DGCs were analyzed. 
(B) Example of Synaptophysin-YFP-transfected DGC. 
(C-F) Fgfr2-deleted and Fgfr1-deleted DGCs do not respond to FGF22. (C) Representative 
images of Synaptophysin-YFP in DGC axons. (D) Quantification of FGF22 responsiveness, 
calculated as total Synaptophysin-YFP signal per mm of axon in FGF22-treated DGCs divided 
by that of untreated DGCs. (E) Synaptophysin-YFP density and (F) size within DGC axons. 
(n=[neurons, experiments] 25, 7 Control; 40, 7 Control+FGF22; 13, 3 Fgfr2-deleted; 18, 3 
Fgfr2-deleted+FGF22; 16, 4 Fgfr1-deleted; 17, 4 Fgfr1-deleted+FGF22) Scale bars in (B) 100 























































Figure 3.5.  Selective deletion of Fgfr2 in interneurons eliminates response to FGF7.  
(A) Experimental scheme. DG and CA3 neurons were cultured from Fgfr2flox/flox pups. At 
DIV1, neurons were sparsely transfected with Cre and Synaptophysin-YFP. 3 nM FGF7 was 
applied on DIV2. At DIV11, neurons were stained for GABA to identify interneurons. 
Synaptophysin-YFP puncta in axons from discretely transfected interneurons were analyzed. 
(B) Example of Synaptophysin-YFP-transfected interneuron. 
(C-F) Fgfr2-deleted interneurons do not respond to FGF7. (C) Representative images of 
Synaptophysin-YFP in interneuron axons. (D) Quantification of FGF7 responsiveness, 
calculated as total Synaptophysin-YFP signal per mm of axon in FGF7-treated interneurons 
divided by untreated interneurons. (E) Synaptophysin-YFP density and (F) size within 
interneuron axons. (n=[neurons, experiments] 10, 3 Control; 15, 3 Control+FGF7; 12, 3 
Fgfr2-deleted; 16, 3 Fgfr2-deleted+FGF22). Scale bars in (B) 100 µm, (C), 10 µm.
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Lemmon and Schlessinger, 2010). Phosphorylation sites within the intracellular domain also 
provide docking sites for adaptor proteins, such as FRS2, PI3K and PLCγ, which activate 
downstream signaling pathways, such as the MAPK/ERK and AKT by FRS2, AKT by PI3K, or 
IP3/DAG/Ca2+ by PLCγ (Mohammadi et al., 1992; Mohammadi et al., 1996; Burgar et al., 2002; 
Hart et al., 2001; Songyang et al., 1993; Hadari et al., 1998; Ong et al., 2001). In order to study 
signaling pathways specifically downstream of FGFR2b, we created FGFR2b mutant constructs 
to perturb specific downstream signaling (Figure 3.6): a kinase dead (KD) mutant and mutants 
lacking the FRS2, PI3K, or PLCγ binding site. I performed two sets of experiments: in the first, I 
overexpressed the mutant FGFR2b constructs in WT neurons (Figure 3.7), and in the second I 
performed a rescue experiment in FGFR2-deleted neurons (Figure 3.8). FGFR2b constructs were 
co-transfected with synaptophysin-YFP into DGC-enriched WT neuronal cultures at DIV1, then 
treated with FGF22 at DIV2 and fixed at DIV11 (Figure 3.7 A). DGCs transfected with empty 
vector (control) responded to FGF22 (Figure 3.7 B, C) with an increase in the density (Figure 3.7 
D) and size (Figure 3.7 E) of synaptophysin puncta. DGCs overexpressing the FGFR2b-KD, 
FGFR2b-FRS2, or FGFR2b-PI3K mutants did not respond to FGF22 in terms of the density or 
size of synaptophysin-YFP, while DGCs overexpressing FGFR2b-PLCγ remained fully 
responsive to FGF22 (Figure 3.7 B-D). Next, I examined whether the mutated FGFR2b 
constructs can restore FGF22-induced Synaptophysin-YFP response in Fgfr2-deleted DGCs. We 
co-transfected Fgfr2b constructs with Cre and Synaptophysin-YFP into DG+CA3 Fgfr2flox/flox 
neuronal cultures at DIV1, treated with FGF22 at DIV2, and assessed Synaptophysin-YFP 
clustering at DIV11 (Figure 3.8 A). As in Figure 3.4, DGCs transfected with non-Cre plasmid 
(control) responded to FGF22, while Fgfr2-deleted DGCs did not (Figure 3.8 B, C). Expression 
of FGFR2b-WT in Fgfr2-deleted DGCs rescued FGF22-responsiveness, but expression of 
FGFR2b-KD, FGFR2b-FRS2-deficient, or FGFR2b-PI3K-deficient mutants did not. 
Interestingly, FGFR2b-PLCγ-deficient rescued FGF22-responsiveness (Figure 3.8 C), although 
only the rescue of Synaptophysin-YFP density (Figure 3.8 D) and not size (Figure 3.8 E) was 
statistically significant. These data indicate that kinase activity of FGFR2b is required to respond 
to FGF22, and that FGFR2b requires signaling downstream of FRS2 and PI3K to induce 




PI3K binding deficient PLCγ binding deficientFRS2 binding deficient
Figure 3.6. Schematic of FGFR2b mutants.
(A) FGF activates FGFR2b upon binding, causing dimerization and cross-autophosphorylation 
of the FGFR2b subunits. Phosphorylation sites provide docking sites for adaptor proteins, which 
are then phosphorylated and activated, ultimately leading to signaling through ERK, AKT, and 
PLCγ signaling pathways.
(B) Schematic of mutations: FGFR2b-KD: Y561E and Y562E mutations to inactivate kinase 
activity. FGFR2b-FRS2-deficient: V332 and T333 deletion to remove FRS2 binding site. 
FGFR2b-PI3K-deficient: Y638A mutation to remove PI3K binding site. FGFR2b-PLCγ-deficient: 



















Figure 3.7. (Following page) FRS2 and PI3K signaling is required downstream of 
FGFR2b for presynaptic response to FGF22 on a WT background in DGCs. (A) 
Schematic of experiment. CA3 and DGCs were cultured from WT P0 pups. At DIV1, the 
neurons were sparsely transfected with Fgfr2b mutant constructs and synaptophysin-YFP. 
Control transfections consisted of synaptophysin-YFP and empty vector without Fgfr2b. 
Neurons were treated with FGF22 at DIV2. At DIV11, neurons were fixed and stained for 
Prox1 to identify DGCs. (B-E) DGCs transfected with Fgfr2b-KD, Fgfr2b-FRS2-deficient, 
and Fgfr2b-PI3K-deficient constructs do not respond to FGF22. (B) Representative images 
of synaptophysin-YFP in axons from DGCs. (C) Total measured binary signal per axon 
length displays total FGF22-responsiveness in control and Fgfr2b-PLCγ groups. (D) 
Quantification of synaptophysin-YFP puncta density in axons. (E) Quantification of average 
size of synaptophysin-YFP puncta. (n = Control: 23 neurons, Control + FGF22: 23 neurons, 
over 5 experiments; Fgfr2b-KD: 23 neurons, Fgfr2b-KD + FGF22: 27 neurons, over 4 
experiments; Fgfr2b-FRS2-deficient: 15 neurons, Fgfr2b-FRS2-deficient + FGF22: 16 
neurons, over 3 experiments; Fgfr2b-PI3K-deficient: 10 neurons, Fgfr2b-PI3K-deficient + 
FGF22: 9 neurons, over 3 experiments; Fgfr2b-PLCγ-deficient: 11 neurons, Fgfr2b-PLC
γ-deficient + FGF22: 14 neurons, over 3 experiments). *p<0.05, and “ns” not significant 
(p>0.05) using Student’s t test to compare FGF22-treated with untreated neurons, within 
each transfection group. Data represents mean ± s.e.m. In scatter plots, each dot 
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Figure 3.8. (Following page)  FRS2 and PI3K signaling is required downstream of FGFR2b 
for presynaptic response to FGF22.
(A) Experimental scheme. DG and CA3 neurons were cultured from Fgfr2flox/flox pups. At 
DIV1, neurons were sparsely transfected with Cre, Fgfr2b constructs, and Synaptophysin-YFP. 
Empty vector was used as a control. Neurons were treated with FGF22 at DIV2 and stained at 
DIV11 for Prox1 to identify DGCs. Synaptophysin-YFP puncta in axons from discretely 
transfected DGCs were analyzed.
(B-E) Expression of FGFR2b-WT or FGFR2b-PLCγ-deficient, but not FGFR2b-KD, 
FGFR2b-FRS2-deficient, or FGFR2b-PI3K-deficient restores FGF22 responsiveness in 
Fgfr2-deleted DGCs. (B) Representative images of Synaptophysin-YFP in DGC axons. 
(C) Synaptophysin-YFP response to FGF22, quantified as in Fig. 9D. (D) Synaptophysin-YFP 
density and (E) size within DGC axons. (n=[neurons, experiments] 7, 3 Control; 7, 3 
Control+FGF22; 6, 3 FGFR2-deleted; 10, 3 FGFR2-deleted+FGF22; 13, 3 FGFR2b-WT; 18, 3 
FGFR2b-WT+FGF22; 8, 3 FGFR2b-KD; 7, 3 FGFR2b-KD+FGF22; 9, 3 
FGFR2b-FRS2-deficient; 13, 3 FGFR2b-FRS2-deficient+FGF22; 12, 3 FGFR2b-PI3K-deficient; 
13, 3 FGFR2b-PI3K-deficient+FGF22; 13, 3 FGFR2b-PLCγ-deficient; 13, 3 FGFR2b-PLC
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While synaptogenic molecules such as FGFs, Wnts, neurotrophins, Eph/ephrins, 
neurexins/neuroligins, and LRRTMs have been identified (Dai and Peng, 1995; Umemori et al., 
2004; Terauchi et al., 2010; de Wit et al., 2011; Dickins and Salinas, 2013; Park and Poo, 2013; 
Siddiqui and Craig, 2011; Xu and Henkemeyer, 2012), the underlying mechanisms through 
which they organize presynaptic differentiation are still being investigated. In this chapter, I 
demonstrated, using both in vivo and in vitro evidence, that FGFRs function within presynaptic 
neurons to respond to target-derived FGF22 or FGF7 (DGCs or interneurons, respectively), and 
that FGFR2b utilizes FRS2 and PI3K signaling to promote synaptic vesicle accumulation. 
Together, I provide novel insights into mechanisms of excitatory and inhibitory presynaptic 
differentiation in the mammalian hippocampus that are critical to proper brain function.  
 
I found that FGFR2b requires kinase activity as well as binding of FRS2 and PI3K for 
synaptic vesicle recruitment in response to FGF22 (Figures 3.7 and 3.8). All three are upstream 
of AKT signaling, and because the effect of mutating any of these three pathways had an equal 
effect in our experiments, it is reasonable to speculate that AKT signaling is involved in 
excitatory presynaptic differentiation downstream of FGFR2b. However, phosphorylation of 
FRS2 by FGFRs activates not only the PI3K/AKT pathway (through Grb2/Gab1 binding; Ong et 
al., 2001), but also the MAPK/ERK pathway (through Grb2/Shp2 binding; Hadari et al., 1998). 
Indeed, deletion of FGFR1 and/or FGFR2 leads to decreases in phospho-MAPK/ERK and 
phospho-AKT levels (Emmenegger et al., 2013, Zhao et al., 2008, Cai et al., 2013, Hoch and 
Soriano, 2006, Loilome et al., 2007, Kondo et al., 2007), and overexpression of FGFR2b or 
FGFR1 increases both phospho-AKT and phospho-ERK levels (Cha et al., 2008, Freeman et al., 
2003, Acevedo et al., 2007). It is known that crosstalk can occur between the PI3K/AKT and 
MAPK/ERK pathways (Moelling et al., 2002), so possibly the MAPK/ERK pathway is being 
triggered congruently. Indeed, a previous study linked FGF2-induced synaptogenic activity to 
the MAPK/ERK pathway: application of MAPK/ERK specific inhibitors blocked FGF2’s 
synaptogenic effect (Li et al., 2002). Finally, recent evidence suggests a role for WAVE 
regulatory complex (WRC) in the regulation of actin cytoskeletal dynamics downstream of 
synaptic cell adhesion molecules (Chia et al., 2014; Chen et al., 2014). Interestingly, FRS2 
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contains a putative WRC binding consensus sequence (Chen et al., 2014), and PI3K can 
contribute to actin cytoskeletal dynamics (Cain and Ridley, 2009). An interesting possibility is 
that FGFR2b-FRS2/PI3K signaling may be controlling the local actin environment at the 
presynaptic terminal for presynaptic differentiation at the site of activation. Finally, two 
interesting questions remain: Does FGFR1b act through the same or distinct signaling pathways 
to control excitatory presynaptic differentiation? And do distinct signaling pathways contribute 
to FGFR-dependent excitatory and inhibitory presynaptic differentiation? In chapter 5, I will 
explore these and other questions that stem from my new insights into FGF-induced excitatory 































CHAPTER IV  






In the previous two chapters, I presented data describing the mechanisms of localized 
FGF22 and FGF7 signaling in inducing presynaptic differentiation in the CA3 region of the 
hippocampal circuit. The hippocampal circuit is grossly organized as a feed-forward loop (Figure 
1.1): entorhinal cortex sends projections into the hippocampal circuit that synapse mainly on the 
dentate gyrus, dentate gyrus cells send projections to CA3 and are one major source of excitatory 
input into CA3, although CA3 pyramidal neurons also connect with each other and receive input 
from the entorhinal cortex; then, simplistically, CA3 projects to the CA1 region and CA1 
projects to subiculum (Witter, 2007). FGF22 and FGF7 are expressed in CA3 at P8 and function 
during early stages of synapse development, although FGF22 is also expressed in the 
infrapyramidal blade of the dentate gyrus at this age (Terauchi et al., 2010). FGF22 requires 
FGFR2b and FGFR1b in dentate granule cells to induce excitatory presynaptic differentiation; 
FGF7 utilizes FGFR2b in interneurons to induce inhibitory presynaptic differentiation 
(Dabrowski et al., 2015). Furthermore, I showed that FGFR2b, at least in the context of 
activation by FGF22, requires kinase activity and signaling that is downstream of FRS2 and 
PI3K to recruit synaptic vesicles, suggesting that synaptogenic FGFs engage signaling pathways 
downstream of FGFRs (Dabrowski et al., 2015). FGFR signaling is known to control important 
shifts in gene expression during development, that underlie cell differentiation (Dailey et al., 
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2005; Olivera-Martinez et al., 2014). This means that synaptogenic FGF signaling is uniquely 
poised to have specific trophic roles in hippocampal neural circuit development: specifically, 
synaptogenic FGFs may trigger changes in gene expression that could have broader effects on 
hippocampal circuitry, including through control of the neurogenic niche in the dentate gyrus and 
induction of dendritic development in dentate granule cells and interneurons. In this chapter, I 
will start by framing the question of “coordinated synapse development” (see Figure 1.1 D and 
Figure 4.1) using neurotrophic signaling in the peripheral nervous system as an example of a 
synaptogenic signal that has cell-wide effects and then briefly describe the reciprocal relationship 
of gene expression and synapse development. Ultimately, I will present some preliminary data 
and my experimental strategy for exploring a more cell-wide effect of FGF signaling guiding 
neuronal integration into the hippocampal neural circuit. 
In the peripheral nervous system, target-derived neurotrophic factors guide numerous 
aspects of integrating the recipient presynaptic neuron into the circuit. Target-derived signals can 
communicate the amount of target that needs to be innervated, the identity of the target, and the 
state of maturation of the target. In the periphery, target-derived cues are important for protection 
from developmental apoptosis, axon targeting, presynaptic development, neurotransmitter 
identity, cell body size, dendrite growth and postsynaptic maturation (Chun and Patterson, 1977; 
Voyvodic, 1989; Landis, 1990; Sharma et al., 2010; Harrington and Ginty, 2013). The fact that 
target-derived cues can both promote presynaptic maturation at the site of signaling, but also 
have distant function in inducing an appropriate level of postsynaptic maturation on the dendrites 
of the same cell provides a mechanism for how synapse development in one region can affect 
synapse development in a distant region, spanning distal tips of the cell. Not all of these changes 
are induced through gene expression: Target-derived NGF promotes postsynaptic development 
in the dendrites of the recipient neuron through a mechanism involving trans-neuronal trafficking 
of the entire NGF-TrkA signaling endosome from the axon terminal into the dendrites (Sharma 
et al., 2010). However, in other instances, gene expression induced by target-derived cues 
appears to be crucial for target-derived effects on dendrites. Motor neurons respond to a target-
derived cue, GDNF, which induces Pea3 transcription factor activation and changes the dendritic 
morphology of the motor neurons in the spinal cord; furthermore this change in dendritic 
morphology is accompanied by a circuitry rearrangement, with a shift in the presynaptic partners 
(Vrieseling and Arber, 2006). Target derived BMP signaling controls the correct sensory 
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Figure 4.1. Model for target-derived role of synaptogenic FGFs in promoting 
neuronal integration into the hippocampal neural circuit.
At P8, CA3-derived FGF22 induces excitatory presynaptic differentiation and FGF7 
inhibitory presynaptic differentiation in CA3. Synaptogenic FGFs may drive changes in 
gene expression in DGCs and interneurons at P14. By P28, FGF-induced gene 
expression can lead to changes throughout the cell, including dendritic changes in both 























innervation of the face by the trigeminal nerve through gene expression by regulating the 
transcription factor Onecut, which is required for correct targeting of sensory neuron projections 
(Hodge et al., 2007). Thus, when contacting the periphery, neurons repeatedly use target-derived 
growth factors to induce gene expression programs that are important for aspects of appropriate 
neural circuit formation. A similar function has yet to be shown between neurons of the central 
nervous system. 
Gene expression and synapse development have a reciprocal relationship. In the 
hippocampus, there are drastic shifts in gene expression over the course of development from 
embryonic stages to the mature circuit, and many of these genes are involved in synapse 
development or function (Mody et al., 2001). Recently, a chromatin regulator, nucleosome 
remodeling and deacetylation (NuRD) complex was shown to control the expression of multiple 
genes involved in presynaptic differentiation in the cerebellum, and loss of NuRD led to 
impaired synaptogenesis in the cerebellum (Yamada et al., 2014). The molecular cues that 
promote drastic shifts in the trancriptome are still incompletely understood, but the shifts in the 
transcriptome reflect the changing requirements of the neuronal circuit. Synapse development 
can induce changes in gene expression, both through intracellular signaling pathways and due to 
synaptic activity itself. At the neuromuscular junction, neuregulin, which promotes synapse 
formation, induces gene expression of acetylcholine receptors in the postsynaptic muscle through 
ErbB2 and ErbB3 signaling (Jo et al., 1995). In neuronal cultures, EphB, a synaptogenic 
molecule, phosphorylates the NMDA glutamate receptor subunit GluN2B and costimulation with 
ephrinB2 and glutamate leads to gene expression of BDNF and CPG15, both of which have been 
in turn implied in synapse development (Takasu et al., 2002). Furthermore, synaptic activity 
triggers intracellular calcium waves in the postsynaptic neuron that induce gene expression 
through activation of CREB (Armstrong and Montminy, 1993; Bito et al., 1996; Hardingham et 
al., 2001; Flavell and Greenberg, 2008). Developmental transcription programs drive genes that 
are required for synapse development, while synapse development in turn triggers gene 
expression. 
Another aspect of dentate gyrus development that target-derived FGF22 from the CA3 
could be regulating is adult neurogenesis. A striking feature of the hippocampal circuit is that the 
subgranular zone in the dentate gyrus is one of a few areas where neurogenesis is maintained in 
the adult brain (Duan et al., 2008; Suh et al., 2009). Adult neural stem cells have the capacity to 
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differentiate into astrocytes or into immature DGCs; their maintenance requires careful 
regulation of the neurogenic niche and of the undifferentiated state of the neural stem cells 
through a combination of extrinsic and intrinsic signals (Duan et al., 2008; Suh et al., 2009). 
Furthermore, the neurogenic niche is highly regulated by synaptic inputs (Suh et al., 2009). 
Decreased neurogenesis correlates with depression (Sahay and Hen, 2007), and certain insults, 
such as epileptic seizures, aberrantly increase rates of adult neurogenesis, leading to abnormal 
circuit connectivity (Parent et al., 1997). Thus understanding how adult neurogenesis is regulated 
within the developing circuit has been of extreme interest (Jessberger and Gage, 2014). Adult 
(five month old) FGF22-KO mice have a decreased number of proliferating cells and immature 
neurons in the dentate gyrus compared to their WT counterparts (Lee and Umemori, 2013), 
suggesting a failure of maintaining the neurogenic niche with loss of FGF22.  
FGF signaling regulates gene expression at multiple stages of development and in 
multiple organs (Dailey et al., 2005, Guillemot and Zimmer, 2011). FGF signaling causes 
phosphorylation of transcription factors, synthesis of new transcription factors, chromatin 
remodeling, and repressor recruitment (Dailey et al., 2005). FGF-induced gene expression is 
required to specify neural tissue (Streit et al., 2000), through activation of ERK (but not AKT) 
signaling (Stavridis et al., 2007), leading to upregulation of Sox genes, which are transcription 
factors required for neuronal cell identity (Pevny and Placzek, 2005). FGF signaling directly 
induces changes in chromatin regulation through controlling expression of the histone 
deacetylase HDAC1; expression of HDAC1 can lead to chromatin remodeling that may direct 
the switch of gene expression towards neural induction (Olivera-Martinez et al., 2014). FGF8 
induces cerebellar fate in rhombomere 1 and an induction of a clear midbrain-hindbrain border 
during early neural development through multilevel control of gene expression, including 
upregulation of FGF18 and FGF17 signaling and induction of negative feedback (Liu et al., 
2003). FGF signaling drives early neuronal development through controlling gene expression. 
Thus, later, synaptogenic FGF signaling could also regulate gene expression in dentate granule 
cells (in response to FGF22) and in interneurons (in response to FGF7). 
 What gene-expression driven cell-wide aspects of DGC or interneuron development 
could FGF22 and FGF7 be coordinating? Given that both FGF22 and FGF7 induce presynaptic 
differentiation, it is likely that synaptogenic FGF signaling induces genes important for 
presynaptic maintenance. However, following the example of target-derived neurotrophic effects 
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in the peripheral nervous system, FGF22 and FGF7 could also promote dendrite growth and 
branching, postsynaptic differentiation (including maturation of dendritic spines), and in the case 
of FGF22, secretion of factors that promote maintenance of the neurogenic niche. Indeed, some 
evidence has surfaced for long-lasting effects of loss of FGF22 and FGF7 on neural circuit 
formation: Firstly, FGF22-KO and FGF7-KO mice have altered seizure susceptibility as adult 
mice, suggesting that early changes in excitatory/inhibitory balance have a long-lasting impact 
(Terauchi et al., 2010). Furthermore, FGF7-KO mice display a rearrangement of the mossy fiber 
circuit from DGCs and an increase in the rate of adult neurogenesis by 2 months of age in the 
absence of seizures, that nonetheless histologically resembles a brain after experiencing seizures 
(Lee et al., 2012). Finally, FGF22-KO mice have decreased rates of adult neurogenesis (Lee and 
Umemori, 2013). Here, I will describe changes in DGC dendritic spines in young adult FGF22-
KO mice, and describe our strategy for identifying FGF22-induced gene expression in DGCs and 




Mice. FGF22-KO and FGF7-KO mice were described previously (Terauchi et al., 2010), Thy1-
GFP-M mice are available at Jackson (Feng et al., 2000), VGAT-Venus mice have been 
previously described (Wang et al., 2009). All mice were on a C57BL/6 background. All animal 
care and use was in accordance with the institutional guidelines and approved by the Institutional 
Animal Care and Use Committees at Boston Children’s Hospital and University of Michigan. 
 
FGF22 gene expression. To assess what genes are induced in DGCs by FGF22 (Figure 4.2), 
gene expression in DGCs was compared between FGF22-KO mice and WT mice at P14, the 
time of transition between early and more mature patterns of activity (Leinekugel et al., 2002). 
DGCs were isolated by microdissecting out the cell layer of the dentate gyrus. RNA was 
extracted, and ran on a microarray by a previous graduate student, Aaron Reifler. I later 
confirmed expression levels of selected genes by microdissecting the dentate granule cell layer 
from two WT and four FGF22-KO mice at P14, isolating RNA and performing quantitative real-
time PCR (QPCR) using Sybr Green QPCR kit (Biorad) and a Biorad QPCR machine. 
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FGF7 gene expression. To assess what genes are induced in interneurons by FGF7 (Figure 4.2), 
gene expression was compared in CA3 interneurons between FGF7-KO and WT mice at P14, the 
time of transition between early and more mature patterns of activity (Leinekugel et al., 2002). 
The FGF7-KO and WT mice were crossed with VGAT-Venus mice, in which Venus-GFP is 
expressed in interneurons. To isolate interneurons, CA3 was dissected from P14 mice and cells 
were dissociated using a papain-based protocol (Brewer and Torricelli, 2007). Briefly, CA3 was 
dissected out of brains in a mammalian ringers solution (1.38 mM NaCl, 5 mM KCl, 10 mM 
Glucose, 10 mM HEPES) supplemented with 5% trehalose (MR-TH), which increases neuron 
survival (Saxena et al., 2012). The CA3 was then finely chopped into 7-10 pieces and placed into 
1 ml HABG-TH (5% trehalose, 2% B27 supplement, 0.5 mM L-glutamine in Hibernate-A 
medium) until ready for dissociation. The CA3 fragments were next transferred into a papain 
solution (34 units papain/ml, 0.05 mM AP5, 0.5 mM Glutamine, 0.005% DNaseI in MR-TH) and 
incubated at 30°C for 30 minutes with occasional gentle swirling. The remainder of the 
procedure was carried out on ice. CA3 cells were spun down at 200xg, resuspended in 1.2 ml 
HABG-TH, spun down and resuspended twice more, and then gently triturated 15 times using a 
fire-polished glass Pasteur pipette. Cells were allowed to settle for one minute, then passed 
through a cell strainer. Remaining fragments were resuspended in 1.2 ml HABG-TH and 
triturated 15 times and passed through the cell strainer. Dissociated cells were spun for 3 
minutes, resuspended in 2 ml HABG-TH, spun down and finally resuspended in FACS buffer 
(10 mM Glucose, 10 mM HEPES, 0.1% Fraction V BSA in L15 medium). FACS sorting was 
performed at the Boston Children’s Hospital Intellectual and Developmental Disabilities 
Research Center Flow Cytometry Core Facility, led by Dick Bennett and performed by Noreen 
Francis on a Becton Dickinson FACSAria machine. Cells that were negative for DAPI (live 
cells) and positivity for GFP (interneurons) were collected into 2 ml of HABG-TH. Cells were 
then spun for 5 minutes at 4°C to pellet the cells and total RNA was isolated using a Qiagen 
RNeasy kit. Total RNA was submitted to the Biopolymers Facility at Harvard Medical School 
for Next Gen sequencing, with amplification using a Nugen SPIA kit, cDNA library preparation; 
DNA-seq is being performed.   
 
Imaging. Thy1-GFP-M (FGF22+/- or FG22-/-) and VGAT-Venus (WT or FGF7-/-) coronal 
sections of 50 µm – 100 µm were made on a vibratome. Sections were stained for GFP (1:5000, 
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A B





Figure 4.2. Strategy to measure FGF-induced genes.
A) To detect FGF22-induced genes in dentate granule cells, the dentate gyrus cell layer 
was dissected from WT and FGF22-KO mice. RNA was isolated and prepared for 
microarray to compare gene expression.
B) To detect FGF7-induced genes in interneurons, mice were crossed with a strain of 
mice with fluorsescently-labeled interneurons. CA3 was dissected, and dissociated cells 
were fluorescence activated cell sorted (FACS) to isolate interneurons. RNA was isolated 
and prepared for RNA-seq to compare gene expression.
WT versus FGF22-KO: WT versus FGF7-KO:
74
Aves). Images were acquired on a Zeiss LSM 700 Confocal microscope using 25x, 40x, and 63x 
objectives. 
 
Results and Discussion 
  
Loss of FGF22 leads to increased dendritic spine density in DGCs in vivo 
 
 FGF22 induces presynaptic differentiation in area CA3, where the primary excitatory 
input comes from DGCs, and I found that FGFR2 and FGFR1 function presynaptically in DGCs 
to respond to FGF22 (Dabrowski et al., 2015). To investigate whether DGCs from FGF22KO 
mice have defects in their dendritic morphology or postsynaptic development, indicative of a 
failure to properly integrate into the hippocampal circuit, I investigated DGC development in the 
FGF22KO and WT mice crossed with GFP-M mice, in which neurons sparsely and at random 
express GFP under the Thy1 promoter (Feng et al., 2000). I found FGF22-KO mice have an 
increased density of dendritic spines in the suprapyramidal blade, compared to WT mice (Figure 
4.3). From my own observations across multiple FGF22-KO, FGF22-het and/or WT animals, I 
had the following preliminary observations: the increase in dendritic spine density is more 
pronounced in the suprapyramidal blade than in the infrapyramidal blade. Dendritic spine 
morphology is different: with longer spines that have smaller spine heads; the proportion of 
“mushroom-shaped” spines is lower in FGF22-KO mice than in controls. Although expression of 
GFP in neurons in the Thy1-GFP-M animals is sparse, it is too dense in the dentate gyrus to 
provide adequate resolution of dendrites from individual neurons; however, differences in 
dendritic morphology that I noted were: dendritic shafts are thinner in FGF22-KO than in 
FGF22-het or WT animals; the dendrites have more uniform thickness compared to FGF22-het 
or WT, which display a range of dendrite thickness. Finally, I also observed occasional ectopic 
dentate granule cells in the inner molecular layer of FGF22-KO dentate gyrus, but not FGF22-
het or WT. Regarding the difference in dendritic spine density between suprapyramidal and 
infrapyramidal blades of the dentate gyrus, it is known that the two blades have slightly different 
anatomy and functional connectivity (Schmidt et al., 2012). Dendritic spine density tends to be 
higher in the suprapyramidal blade (Claiborne et al., 1990), the suprapyramidal blade receives 










Figure 4.3. Density of dendritic spines increases on FGF22-KO DGCs.
A) Partial schematic of hippocampal circuit to show molecular layer in suprapyramidal 
blade of dentate gyrus, where dendritic spine change is observed.
B) Example images of dendritic spines in FGF22-het and FGF22-KO (from two separate 
animals, each).
C) Quantification of FGF22-KO dendritic spines relative to WT.
CA3
DGA
Animal 1 Animal 2
Animal 1 Animal 2
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from the medial entorhinal cortex (Squire, 1992; Tamamaki, 1997), and finally the 
suprapyramidal blade may have a greater role in pattern separation than the infrapyramidal blade 
(Schmidt et al. 2012). Thus, FGF22 may have a role in postsynaptic development of DGCs in the 
dentate gyrus affecting the connectivity between the entorhinal cortex and dentate gyrus. The 
change in synapse number could be due to an increase in functional excitatory synapses, or an 
increase in immature, non-functioning excitatory synapses with or without a concurrent decrease 
in functional excitatory synapses: thus synaptic function in dentate granule cell of FGF22-KO 
animals merits closer investigation.   
  
FGF22 induces gene expression in DGCs, including genes implicated in neurogenesis and 
dendritic spine formation  
 
 FGF22 is expressed by CA3 pyramidal neurons and subsets of dentate granule cells in the 
infrapyramidal blade of the dentate gyrus at P8 (Terauchi et al., 2010). By P21, expression levels 
of FGF22 are markedly decreased throughout the dentate gyrus (Toth et al., 2013), suggesting 
that changes observed in dendritic spines of DGCs are a result of earlier FGF22 expression. One 
model is that early, target-derived, synaptogenic FGF22 induces changes in gene expression that 
lead to altered dendritic spine growth. In order to identify the genes controlled by FGF22 that 
could be promoting adult neurogenesis (Lee and Umemori, 2013) and dendritic spine density, we 
compared gene expression in FGF22KO and WT DGCs at P14, a time at which early presynaptic 
differentiation in response to FGF22 is ending (see Dabrowski et al., 2015), but at which FGF22 
could already have induced genes important for network development in the DGCs. From the 
seventy candidate genes identified by microarray, I selected genes that have a significant change 
in gene expression on microarray (an absolute DiffScore of more than ±13, which corresponds to 
a p-value of 0.05) and that have been linked to neurogenesis or postsynaptic development 
(Figure 4.4). Many of the genes that I do not describe here have not been directly linked to 
dendritic spine development or neurogenesis yet, but could still play an uncharacterized role. Of 
note, some of the genes (BMP4, IGF2, COL1A1, COL4a1, neuronatin, Gabra2) that I selected to 
describe below were also identified for their patterns of expression levels over hippocampal 
development, from embryonic to adult (online supplemental gene expression data for Mody et 





Expression in KO Relative to WT
Igf2
-21.096 Bone morphogenetic protein 4 (Bmp4)




-18.133 Ets2 repressor factor (Erf)
-29.716 Zinc finger protein 365 (Zfp365) /
DISC1-Binding Zinc finger protein (DBZ)
Col1a1
Col4a1
-33.444 Procollagen, type I, alpha 1 (Col1a1)
-21.645 Procollagen, type IV, alpha 1 (Col4a1)
Col6a1
Lrrtm3
-52.859 Procollagen, type VI, alpha 1 (Col6a1)





Solute carrier family 9, isoform 3 regulator 1 
(Slc9a3r1) / Sodum-hydrogen exchanger 3 (Nhe3)




-25.554 Adrenergic receptor, alpha 2a (Adra2a)
Gabra2
Cd200
15.156 Gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 2 (Gabra2)
16.997 Cd200 antigen (Cd200)













B Figure 4.4. FGF22-induced Gene expression in 
Dentate Granule Cells.
A) Selected genes from microarray of gene 
expression in dentate granule cells of FGF22-KO 
relative to WT at P14. Genes then confirmed by 
QPCR highlighted in green. Genes ordered by 
potential role in DGCs (as described in main text.)
B) Expression of selected genes by QPCR in 
dentate granule cells of FGF22-KO relative to WT 
at P14. 
78
network. I will describe below the rationale for how the following genes may mediate FGF22-
induced changes in the hippocampal circuit, but ultimately these candidates will need to be 
verified experimentally for their biological function.  
Among the candidate genes that control the neurogenic niche, I have selected two 
secreted proteins (BMP4 and IGF2) and two cytosolic proteins (ERF and DBZ) to discuss here, 
all of which were downregulated in FGF22KO DGCs. Furthermore, I confirmed that BMP4 and 
IGF2 were downregulated in FGF22KO DGCs relative to WT DGCs using QPCR (Figure 4.4). 
Proteins secreted in a paracrine manner have important roles in controlling stem cell 
niches through regulating the proliferation and differentiation of the stem cells (Scadden, 2006; 
Duan et al., 2008). BMP4 and IGF2 may be secreted from mature DGCs to regulate neurogenesis 
in the subgranular zone. Regulation of intrinsic signaling within neural stem cells is also 
important for maintenance of the neurogenic niche (Duan et al., 2008). A decrease in the 
expression of ERF and DBZ may reflect a decrease in their expression in mature DGCs, where 
they could have a role in inducing extracellular and secreted proteins important for maintenance 
of the neurogenic niche, or they could represent a decrease in the expression of intrinsic factors 
within the neurogenic niche due to decreased pro-neurogenic signaling from mature DGCs.  
BMP4 is a secreted growth factor that is highly expressed throughout the adult brain, and 
in the dentate gyrus it is highly expressed both in the granule cell layer and the molecular layer 
(Mikawa et al., 2006). BMP4 has a complex role in neurogenesis that is both age and 
concentration dependent. BMP4 inhibits neurogenesis in vitro and promotes differentiation 
towards a neuronal fate (Kalyani et al., 1998; Li et al., 1998; Shou et al., 1999; Howard et al., 
2000; Rios et al., 2004), but at lower concentrations it promotes neurogenesis, specifically by 
promoting survival of newly generated cells (Shou et al., 2000; Mabie et al., 1999). In adult 
animals, constitutive overexpression of BMP4 led to decreased neurogenesis; in fact, BMP4 was 
downregulated in response to activity, which increases neurogenesis (Gobeske et al., 2009). 
BMP4 inhibits neural differentiation by inhibiting the activity of a neurogenic transcription 
factor in neural stem cells, thus maintaining their undifferentiated state (Kamiya et al., 2011). 
BMP4 overexpression in dentate gyrus in vivo slowed down the rate at which newly born DGCs 
matured (Bond et al., 2014); BMP4 inhibition increased neurogenesis at the cost of losing 
quiescent cells (Bonaguidi et al., 2005; Bond et al, 2014). This suggests that FGF22 may induce 
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BMP4 in the dentate gyrus to maintain neural stem cells in an undifferentiated state during 
adulthood. 
In contrast, FGF22 may induce IGF2 to promote neurogenesis. IGF2 is a secreted growth 
factor that has numerous roles in brain development (Fernandez and Torres-Aleman, 2012). 
IGF2 in the cerebrospinal fluid promotes embryonic neurogenesis throughout the cerebral cortex 
– IGF2-KO animals have markedly decreased cortical size at birth (Lehtinen et al., 2011). IGF2 
expressed by neural stem cells in the dentate gyrus promotes the proliferation of neural stem 
cells (Bracko et al., 2012). Thus, FGF22 may be important for regulating a balance between 
maintenance and differentiation of neural stem cells. ERF is a transcriptional repressor that 
inhibits neuronal precursor proliferation and promotes neural differentiation in the developing 
neural plate of Xenopus (Janesick et al., 2013). Decreased ERF expression in FGF22-KOs may 
lead to a depletion of the subgranular zone neurogenic niche before adulthood. DBZ was 
identified for its interaction with Disrupted-in-Schizophrenia 1 (DISC1) (Hattori et al., 2007). 
DISC1 promotes adult neurogenesis in response to GABA-ergic signaling in the subgranular 
zone (Kim et al., 2012). DISC1 is also important in slowing the rate of maturation of newborn 
dentate granule cells – loss of DISC1 leads to smaller soma size, abnormal dendrites, and 
mislocalization of newborn dentate granule cells into the molecular layer of the dentate gyrus 
(Duan et al., 2007). Thus, dysregulation of DBZ in FGF22-KOs may lead to dysregulation of 
DISC1 and a failure of immature neurons to respond appropriately to neurogenic factors, leading 
to defects in adult neurogenesis. 
FGF22-induced genes in the dentate gyrus that control neurogenesis could reflect a 
highly complex switch from neurogenesis during early development to adult neurogenesis, in 
which the balance must be maintained between stem cell maintenance, proliferation, and 
neuronal differentiation.  The defect in neurogenesis in FGF22-KO mice could be due to 
decreased proliferation of neural precursors and/or altered programs of neural differentiation in 
the dentate gyrus that have led to maintenance of fewer precursors. Since FGF22 is expressed in 
the infrapyramidal blade of the dentate gyrus at P8, (although expression is nearly gone by P21) 
(Terauchi et al., 2010; Toth et al., 2013), FGF22 expressed directly within the dentate gyrus 
could be inducing genetic programs required for the maintenance of the neurogenic niche. 
Indeed, there appears to be more adult neurogenesis in the infrapyramidal blade compared to the 
suprapyramidal blade (Snyder et al., 2009). Another interesting model is that target-derived 
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FGF22 from the CA3 induces expression of genes involved in maintenance of the neurogenic 
niche in the dentate gyrus (model outlined in Figure 4.1). Further experiments (described in 
Chapter 5) will be required to distinguish between the role of CA3-derived versus DG-derived 
FGF22, although it is possible that both are involved. 
FGF22-KO mice have an increased density in dendritic spines in the molecular layer of 
the suprapyramidal blade in the dentate gyrus at P28 (Figure 4.3), three weeks after high 
expression of FGF22 in CA3 at P8 (Terauchi et al., 2010). At P8, FGF22 is also expressed in the 
infrapyramidal blade, but not the suprapyramidal blade where the defects were observed. I 
propose a model in which target-derived FGF22 from the CA3 controls changes in gene 
expression that then induce changes in dendritic spines of DGCs (model in Figure 4.1), although 
the contribution of CA3-derived versus DG-derived FGF22 still needs to be clarified (see 
Chapter 5 for more detail). From the microarray data, I have selected several candidate genes 
that may play a role in dendritic spine density: Col1a1, Col4a1, Col6a1, Lrrtm3, Nhe3, Mylk, 
Neuronatin, DBZ (mentioned above), Adra2a, Gabra2, and CD200. All of the genes are 
downregulated in FGF22KO DGCs, except for Neuronatin, Gabra2, and CD200, which are 
upregulated in FGF22KO. I have confirmed the changes in expression for IGF2, CD200, and 
LRRTM3 (Figure 4.4) using QPCR. I will describe here how these genes could be inducing a 
change in dendritic spine density.  
Dendritic spines are the protrusions from dendrites and the postsynaptic locations of 
excitatory synapses. The spines are highly dynamic during development that stabilize with 
maturation; their morphology and number is carefully regulated by a host of molecular cues, 
including secreted factors, extracellular matrix proteins, cell adhesion proteins, regulators of 
cytoskeleton, metabolic regulators, and neurotransmitter proteins (Bhatt et al., 2009). An 
increase in dendritic spines in FGF22-KO may represent either an increase in mature, stable 
spines on the dendrites (with a concurrent increase in excitatory drive), or an increase in the 
number of unstable, highly motile dendritic spines (with a possible decrease in excitatory drive). 
Thus, loss of FGF22 could lead to loss of a negative signal for pruning away synapses, or loss of 
a stabilizing signal to increase mature stable synapses and decrease unstable synapses. 
In terms of stabilizing cues, there are a number of FGF22-induced genes that could be 
important for stabilization of dendritic spines, and the loss of which could lead to an increase in 
unstable spines.  First, careful regulation of the extracellular matrix, including composition of 
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collagens in the extracellular space, is important for synapse stabilization (Fox et al., 2007; 
Kurshan et al., 2014). Thus, FGF22-induced collagens (Col1a1, Col4a1, and Col6a1) could play 
important roles in stabilizing dendritic spines; their loss could lead to destabilization and an 
increase in immature spines. Likewise, cell adhesion molecules are important for maturation and 
stabilization of the postsynaptic density, including members of the leucine-rich transmembrane 
family (de Wit and Ghosh, 2014). Clustering of LRRTMs induces postsynaptic differentiation 
(Linhoff et al., 2009), thus FGF22-induced LRRTM3 may be important for stabilization of 
dendritic spines in DGCs. Nhe3 binds Shank2 and to the actin cytoskeleton (Han et al., 2006;), 
and Shank2 is a postsynaptic density protein important for postsynaptic stabilization (Boeckers et 
al., 2002), thus FGF22-induced regulation of Nhe3 levels in postsynaptic densities may be 
important for dendritic stabilization. DBZ, which binds to DISC1 (Hattori et al., 2007), may also 
be involved in regulating the postsynaptic density through its interaction with DISC1, which is 
important for regulating dendritic spines (Carlisle et al., 2011; Duan et al., 2007; Hayashi-Takagi 
et al., 2009). Regulation of the actin cytoskeleton is important for dendritic spine development 
(Bhatt et al., 2009); Mylk regulates myosin light chain, and both Mylk and myosin light chain 
regulate actin cytoskeleton in dendritic spines (Zhang et al., 2005; Amparan et al., 2005, Lei et 
al., 2001, Naisbitt et al., 2000). FGF22-induced Mylk may be important for regulating 
cytoskeletal dynamics to control appropriate synaptic density. Additionally, dendritic spines 
require regulation of local protein translation (Martin and Zukin, 2006). Neuronatin is suppressed 
by FGF22 (upregulated in FGF22KO DGCs compared to WT): it is a proteolipid that regulates 
calcium levels and induces neural fate in embryonic stem cells, and appears to control local 
translation in dendrites of cultured hippocampal neurons (Joseph, 2014), suggesting that 
upregulation of neuronatin in FGF22-KO DGCs may misregulate postsynaptic protein 
translation, leading to defects in dendritic spine morphology. Thus, FGF22 may regulate the 
density of dendritic spine on numerous levels, from extracellular matrix to control of the actin 
cytoskeleton and local protein synthesis in spines.  
 Dendritic spine density in DGCs in response to FGF22 may be a result of altered 
regulation of postsynaptic function in FGF22-KO DGCs. The adrenergic receptor, Adra2a, 
which is induced by FGF22, regulates postsynaptic function at dendritic spines in the prefrontal 
cortex (Wang et al., 2007). Blocking Adra2a in cultured neurons leads to increased density of 
spines and increased length of dendritic spines (Hu et al., 2008). On the other hand, the GABA-A 
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receptor subunit, Gabra2, is suppressed by FGF22 signaling and has also been implicated in 
dendritic spine development – loss of Gabra2 in adult born neurons in the olfactory bulb leads to 
decreased dendritic spine density (Pallotto et al., 2012). Thus, the increased spines in FGF22KO 
DGCs could be due to decreased Adra2a or increased Gabra2, through modulation of 
postsynaptic function and maturation.  
Finally, FGF22-KO DGCs may have increased dendritic spine density through an altered 
interaction with microglia. Microglia have an important role in eliminating dendritic spines 
through phagocytosis (Salter and Beggs, 2014; Ueno and Yamashita, 2014). CD200 is a 
protective signal against microglial phagocytosis (Elward and Gasque, 2003). CD200 is 
upregulated in FGF22-KO DGCs, thus may lead to an overexpression of a protective signal on 
dendritic spines and a failure to eliminate them in a microglia-dependent manner, which may 
lead to an increase in the density of mature dendritic spines in FGF22-KO DGCs. 
 Synaptogenic FGFs may be acting as a target-derived cue (as in the model in Figure 4.1) 
to promote the integration of neurons into the neural network. Indeed, FGF22 induces changes in 
gene expression in DGCs (Figure 4.4), and DGCs have increased dendritic spine density (Figure 
4.3). At the time of writing this chapter, the results of the RNA-seq screen for genes induced by 
FGF7 in interneurons had not yet come in. We will be interested in comparing the genes induced 
by FGF7 in interneurons with the genes induced by FGF22 in DGCs, to understand which genes 
may be required in both DGCs and interneurons to promote the integration of neurons into the 
circuit. Furthermore, I have examined interneurons in the CA3 of WT and FGF7-KO mice that 
were crossed with the Vgat-Venus mice to fluorescently label interneurons. My preliminary 
observations are that CA3 interneurons in the stratum oriens, which form synapses onto CA3 
pyramidal neurons in the stratum radiatum and stratum lucidum (Freund and Buzsaki), have 
smaller cell body size, decreased number of primary dendrites, and decreased dendritic 
branching. Because these observations are preliminary, they are being followed up by other 
members in the lab.  However, if synaptogenic FGFs prove to act as target-derived factors for 
dendritic and postsynaptic development, and regulation of the neurogenic niche, this will present 














Conclusions and Future Directions 
 
 I have described here my work on the role of FGFRs in excitatory and inhibitory synapse 
differentiation. First in Chapter 2, using in vivo and in vitro data, I demonstrated that distinct, 
overlapping sets of FGFRs are responsible for excitatory versus inhibitory presynaptic 
differentiation in response to FGF22 or FGF7 in the CA3 of the hippocampus: FGFR2b and 
FGFR1b are required for excitatory presynaptic differentiation in response to FGF22, and 
FGFR2b alone is required for inhibitory presynaptic differentiation in response to FGF7 
(Dabrowski et al., 2015). Next in Chapter 3, using an in vitro assay, I demonstrated that the 
receptors are functioning in the presynaptic cell to induce synaptic vesicle accumulation within 
the axon: FGFR2 and FGFR1 in dentate granule cells respond to FGF22, and FGFR2 in 
interneurons responds to FGF7. Using an in vitro assay, I demonstrated that FGFR2b requires 
kinase activity, and binding of the adaptor proteins FRS2 and PI3K to induce presynaptic 
differentiation in DGCs in response to FGF22, likely through a mechanism involving AKT 
signaling (Dabrowski et al., 2015). Finally, in Chapter 4, I presented preliminary data on the 
roles of FGF22 in incorporating DGCs into the hippocampal circuit by modulating dendritic 
development, possibly through control of genes induced by FGF22 in dentate granule cells. 
Together these data suggest a model in which FGFR2b and FGFR1b, through their differential 
use at excitatory versus inhibitory axon terminals, provide redundant specificity to FGF signaling 
in excitatory versus inhibitory presynaptic differentiation.  
 These studies open up many future directions, which can be categorized into six broad 
questions: 1) What is the relationship between FGFR2b and FGFR1b signaling in excitatory 
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neurons and are there differences in FGFR2b function in excitatory versus inhibitory neurons? 2) 
Do FGFR2b and FGFR1b recruit different proteins to the excitatory and inhibitory presynaptic 
bouton? 3) Do FGFRs expressed in other cell types have a role in FGF22-induced excitatory 
presynaptic differentiation or FGF7-induced inhibitory presynaptic differentiation? 4) Do genes 
induced by FGF22 and FGF7 in dentate granule cells and interneurons, respectively, promote 
DGC and interneuron integration into the hippocampal circuit? 5) What are the functional 
consequences of loss of FGFR2b or FGFR1b in the hippocampal circuit? And ultimately, 6) 
What is the role of FGF signaling in epilepsy and neurological disease? I will outline here plans 
for future experiments to address these questions and further our understanding of FGF signaling 
in the development of healthy brain circuits. 
 
 
1. FGFR2b and FGFR1b – dissecting differences 
 
 FGFR2b and FGFR1b are required in DGCs for FGF22 to induce excitatory presynaptic 
differentiation; FGFR2b, but not FGFR1b, is required for FGF7 to induce inhibitory presynaptic 
differentiation (Dabrowski et al., 2015). The overlap in FGFR2b requirement for excitatory and 
inhibitory presynaptic differentiation, but uniqueness of FGFR1b requirement for excitatory 
differentiation, leads to several questions: since FGFR2b is acting in different cell types, why is 
FGFR1b required for excitatory presynaptic differentiation, and not just the differential 
expression of FGFR2b in excitatory or inhibitory axon terminals? Does FGFR1b have a unique 
role in signaling excitatory presynaptic differentiation or does it somehow suppress inhibitory 
presynaptic differentiation? Do FGFR2b and FGFR1b have similar functions in recruitment of 
excitatory synaptic vesicles? Are both receptors required to activate gene expression in response 
to FGF22? Here, I will outline some experiments to address these questions (Figure 5.1). 
 I have demonstrated that signaling downstream of FRS2 and PI3K is required for 
FGFR2b to respond to FGF22, but what is the response of FGFR1b to FGF22 or FGFR2b to 
FGF7? To address this, in vitro, cell autonomous rescue experiments transfecting mutant 
FGFR1b constructs into dentate granule cells and mutant FGFR2b constructs into interneurons, 
together with synaptophysin-YFP, can be performed (Dabrowski et al., 2015). Additionally, to 





































Figure 5.1. Schematic of experiments to dissect signaling differences 
between FGFR2b and FGFR1b. 
A) Dissecting signaling pathways downstream of FGFR1b in response to FGF22 
and downstream of FGFR2b in response to FGF7.
B) Schematic of Opto-FGFR experiment to track recruitment of synaptic vesicles to 
activated FGFRs (Opto-FGFR2 or Opto-FGFR1) in real time.



























interchangeable for rescue of FGF22 responsiveness, chimeric FGFR2b-1b mutants can be made, 
with the extracellular domain of one receptor fused to the intracellular domain of the other 
receptor. As a reminder of the experimental design, cell autonomous manipulation is achieved by 
sparse transfection of neuronal cultures with synaptophysin-YFP, a fluorescently-tagged marker 
of synaptic vesicles, along with Cre (to induce cell-autonomous receptor deletion in transfected 
conditional KO neurons) and/or FGFR mutant constructs. These experiments can answer several 
questions: Does FGFR2b activated by FGF7 also recruit FRS2 and PI3K for inhibitory 
presynaptic differentiation, similar to excitatory activated by FGF22? Does FGFR1b require 
FRS2 and PI3K in response to FGF22, similar to FGFR2b? Is the intracellular portion of FGFR2 
fused with extracellular FGFR1b (or vice versa) functionally equivalent to WT FGFR2b? If there 
are differences between FGFR2b and FGFR1b response to FGF22, it is possible that it is due to 
different affinity of FGF22 for the receptor, or it could due to differences in the intracellular 
kinase activity between FGFR2 and FGFR1. In terms of signaling pathways required for 
presynaptic differentiation, FGFR2b in response to FGF22 or FGF7 and FGFR1b in response to 
FGF22 could all utilize the same signaling pathways. Alternatively, FGFR2b could use the same 
signaling pathways, but FGFR1b could use distinct pathways, such as the PLCγ pathway. 
Another alternative possibility is that excitatory and inhibitory synaptic vesicle accumulation 
requires different signaling pathways downstream of FGFR2b. The three pathways I test (ERK, 
AKT, and PLCγ) are the major pathways downstream of FGFRs, however there are additional 
pathways implicated in FGFR signaling transduction, such as the STAT pathway, and 
mechanisms of negative feedback, that could be unique between receptors (Ornitz and Ioth, 
2015). Some downstream regulation is unique: for example, in the absence of ligand activation, 
the C-terminus of FGFR2 is bound by Grb2, displacing PLCγ (Timsah et al., 2014), and 
supporting the possibility of unique signaling pathways between FGFR2b and FGFR1b. 
Signaling downstream of the receptors merits further study. 
 Are synaptic vesicles immediately recruited to the site of FGFR activation on the scale of 
minutes to hours? For example, Wnt7a application to cultured hippocampal neurons induces 
excitatory synapses within an hour in a transcription-independent manner (Ciani et al., 2011). 
Immediate recruitment of synaptic vesicles to the site of FGFR activation suggests a direct 
mechanism of action. To monitor local, temporal dynamics of synaptic vesicle recruitment to the 
site of FGFR activation, one would want to locally manipulate FGFR activation and use live 
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imaging to monitor the recruitment of synaptic vesicles. One possibility would be to locally 
apply FGF22 or FGF7, and monitor the accumulation of synaptic vesicles at the site of 
application over the next twenty-four hours. However, because FGF22 and FGF7 may diffuse 
away from the site of application, a recently developed optogenetic technique for manipulation 
of the FGFR activation can be utilized (Opto-FGFR; Kim et al., 2014 and Grusch et al., 2014). 
Opto-FGFRs are constructs in which the intracellular domain of an FGFR was fused at the C 
terminus with the photolyase homology region of photosensory cryptochrome 2 from 
Arabidopsis thaliana  (Kim et al., 2014) or the light-oxygen-voltage domain of aureochrome 
photoreceptors from stramenopiles (Grush et al., 2014). Endogenous cryptochromes and 
aureochrome photoreceptors dimerize when exposed to blue light, thus the Opto-FGFR construct 
dimerizes when blue light is shined upon it, inducing cross auto-phosphorylation and activation 
of FGFR signaling, as measured by ERK, AKT, and PLCγ phosphorylation, and cell growth and 
migration. The extracellular portion is excluded to avoid interference from endogenous ligands. 
To study the dynamics of synaptic vesicle recruitment to the site of FGFR activation, Opto-
FGFR1 and Opto-FGFR2 constructs would be transfected into neurons along with 
synaptophysin-mCherry (using red fluorescence might minimize the possibility of activation of 
Opto-FGFR from the synaptophysin fluorescence during imaging). Laser activation using blue 
light will be followed by live imaging of the neurons and evaluation of the intensity and size of 
Syn-mCherry at the site of stimulation relative to unstimulated sites. These experiments will help 
address whether there are differences between the receptors in terms of their temporal dynamics 
of synapse vesicle recruitment. Furthermore, mutated constructs of the Opto-FGFRs can be 
made, using the intracellular domains of those shown in Figure 3.6, to test the contribution of 
individual signaling pathways to the local recruitment of synaptic vesicles in response to FGFR 
activation.  
Using Opto-FGFR, another question that can be answered is if FGFR activation induces 
an increase in synaptic vesicle exocytosis at the site of synaptic vesicle accumulation. During 
spontaneous synaptic vesicle pausing in the absence of postsynaptic contact, synaptic vesicles at 
pause site frequently exocytose (Ahmari et al., 2000). However, as a synapse differentiates, the 
synaptic vesicles begin to form heterogenous pools, some of which are in the readily-releasable 
pool, while others are in recycling or reserve pools (Alabi and Tsien, 2012). From electron-
microscope imaging in vivo, FGF22 and FGF7 appear to promote the recruitment of synaptic 
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vesicles into the readily releasable pool (Terauchi et al., 2010). Thus, to address the dynamics of 
acutely-accumulating synaptic vesicles in response to FGFR stimulation, Opto-FGFR can be 
expressed in neurons in vitro together with a synapto-pHluorin, such as VGLUT1-pHlorin for 
excitatory synapses (Balaji and Ryan, 2007), a synaptic marker in which a pH-sensitive GFP is 
in the vesicle lumen and fluoresces when synaptic vesicle exocytose and are alkalinized. By 
providing a potassium challenge that depolarizes the axon, the magnitude of exocytosis 
(measured as an increase in VGLUT1-pHluorin fluorescence) at the site of FGFR-activation can 
be assessed. An increase in exocytosed synaptic vesicles at the site of FGFR activation supports 
the idea of direct recruitment of synaptic vesicles into a readily-releasable pool.  
 The ultimate readout of FGFR signaling is gene expression. We have identified genes 
expressed in response to FGF22 in DGCs and are identifying genes induced in response to FGF7 
in interneurons (see Chapter 4). Do both FGFR2b and FGFR1b contribute to gene expression? 
Do they control expression of unique genes, or are the two receptors redundant? To answer these 
questions, the ability of FGF22 to induce candidate gene expression in dentate granule cells in 
hippocampal neuron cultures from FGFR2b-KO, FGFR1b-KO, or WT mice can be tested. We 
interrogated changes in gene expression in FGF22-KO animals at P14 in vivo, about one week 
after peak expression of FGFs in the CA3, thus candidate genes could be assessed in vitro one 
week after FGF22 application. RNA could be isolated from the whole hippocampal culture and 
target genes could be measured by QPCR. To measure gene expression specifically in DGCs, 
fluorescence in situ hybridization on the cultured neurons could be performed to detect mRNA of 
the target genes in Prox1+ DGCs (Swanger et al., 2011). It is possible that only one of the two 
receptors induce gene expression in response to FGF22, or that the two receptors act through 
distinct pathways to induce gene expression and induce different genes. This could shed light on 
the differences in signaling induced by FGFR2b and FGFR1b activation. 
Understanding the detailed dynamics of synaptogenic FGFR2b and FGFR1b has broader 
implications for FGF studies. There are eighteen secreted FGF ligands, but only seven FGFRs, 
and yet FGF signaling displays a remarkable degree of specificity in their function (Ornitz and 
Itoh, 2015; Guillemot and Zimmer, 2011; Dailey et al., 2005). FGF22 and FGF7 maintain their 
specific effect on excitatory and inhibitory presynaptic differentiation when bath applied in vitro, 
that is FGF22 induces a more robust increase in VGLUT1 puncta than VGAT puncta, while 
FGF7 induces a more robust increase in VGAT than in VGLUT1 puncta (unpublished results, 
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observed by myself and multiple lab members). In the absence of spatial restriction of FGF 
secretion, how does FGF7 activation of FGFR2b in interneurons have a more robust effect on 
inhibitory presynaptic differentiation than FGF22 activation of FGFR2b in interneurons does?  
Little is known about the differences in how different FGFs activate the same FGFR; or how the 
same FGFR responds to different ligands. Probing these questions would be of broader interest 




2. Proteins recruited by FGFRs in presynaptic boutons 
 
 FGF22 induces excitatory presynaptic differentiation and FGF7 induces inhibitory 
presynaptic differentiation in hippocampal CA3 (Terauchi et al., 2010). I showed that FGFR2b 
and FGFR1b are required in the presynaptic excitatory neurons (dentate granule cells) and 
FGFR2b is required in the presynaptic inhibitory neurons (interneurons) (Dabrowski et al., 
2015). I also showed that FGFR2b and FGFR1b, when overexpressed, localize to presynaptic 
boutons in axons (Dabrowski et al., 2015). Finally, I found that FGFR2b requires kinase activity, 
and signaling downstream of FRS2 and PI3K to induce excitatory presynaptic differentiation in 
response to FGF22 (Dabrowski et al., 2015). This suggests that FGFRs form signaling 
complexes in the presynaptic bouton that recruit synaptic vesicles to the differentiating 
presynaptic terminal. Questions remain: What sorts of proteins complex with activated FGFRs to 
induce excitatory versus inhibitory presynaptic differentiation? Are the proteins recruited by 
FGFR2b and/or FGFR1b to excitatory versus inhibitory axon terminals different? My results 
suggest that FRS2 and PI3K will be in that complex, but there are two distinct FRS2 proteins, 
FRS2α and FRS2β, and multiple proteins bind to FRS2 when FGFRs are activated (Ong et al., 
2000). I hypothesized at the end of Chapter 3 that FRS2 and PI3K could be activating either the 
AKT pathway, or alternatively, could be recruiting the WAVE receptor complex (WRC) (Chen 
et al., 2014) to induce changes in F-actin – directly detecting WRC at activated FGFRs would 
strongly implicate it in presynaptic differentiation. Likewise, there are differences in regulation 
of synaptic vesicles at excitatory and inhibitory presynaptic terminals (Augustin et al., 1999; 
Gitler et al., 2004), suggesting that there may be distinct mechanisms to recruit synaptic vesicles 
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in response to FGF22 and FGF7. Differences in the required pathways to recruit synaptic 
vesicles at excitatory and inhibitory terminals could explain why FGF22 and FGF7 utilize 
distinct sets of FGFRs for presynaptic differentiation (Dabrowski et al., 2015). This question is 
related to the previous question (see Figure 5.1), but now I focus on specific proteins recruited to 
FGFR2b or FGFR1b in response to synaptogenic FGFs, with the hope of uncovering novel 
protein interactions (Figure 5.2). I propose to use proteomics to A) probe the proteins 
immunoprecipitated with FGFR2 or FGFR1 from excitatory or inhibitory neurons in the 
presence or absence of FGF22 or FGF7, and B) probe the proteins present at excitatory and 
inhibitory synapses in the presence or absence of synaptogenic FGF signaling. I acknowledge 
that the experiments I propose below are technically challenging, because FGFRs are expressed 
in many cell types in the hippocampus but the effect I am looking for is very local, because 
available antibodies are not specific for –b verus –c splice forms of FGFR2 or FGFR1, and 
because proteomics requires a fairly high sample volume. However, the answers these 
experiments yield may be very interesting for gaining a deeper understanding of the differences 
between FGFR2b and FGFR1b signaling, and context-dependent differences in FGFR signaling.  
 To address what proteins assemble at activated FGFRs in excitatory versus inhibitory 
synaptic terminals, one could immunoprecipitate FGFR2 or FGFR1 from excitatory or inhibitory 
neurons and identify associated proteins. I propose to isolate excitatory or inhibitory neurons 
from the hippocampal CA3 from P8 animals, which is when FGF22 and FGF7 are highly 
expressed in CA3 (Terauchi et al., 2010), stimulate the isolated neurons with FGF22 or FGF7, 
and then immunoprecipitate FGFR2 or FGFR1. In order to isolate the subpopulations of neurons, 
one could use FACS sorting (as described in chapter 4); for excitatory neurons this would require 
a fluorescent reporter expressed in excitatory neurons, for example by combining Cre-induced 
YFP expression with a Cre expressed under the VGLUT1 promoter (Allen Institute for Brain 
Science, 2009); for inhibitory neurons, VGAT-Venus mice described in Chapter 4 could be used. 
After isolating the neuronal sub-population, excitatory neurons would be stimulated with FGF22 
and FGFR2 and FGFR1 immunoprecipitated, and inhibitory neurons stimulated with FGF7 and 
FGFR2 immunoprecipitated. The samples would need to be manipulated in the presence of 
phosphatase inhibitors. The proteins could then be run out using two-dimensional protein 
electrophoresis to identify differences in spots, which could then be excised and identified using 
matrix-assisted laser-desorption ionization mass spectrometry (MALDI-MS); or, all of the 
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Figure 5.2. Schematic of experiments to probe for changes in FGFR-induces synaptic 
proteasome. 
A) To test differences proteins recruited to FGFR2b and FGFR1b in response to FGF22 or 
FGF7 in excitatory or inhibitory neurons, neurons will be fluorescence activated cell sorted 
(FACS) to isolate an excitatory or inhibitory neuron population at P8. Excitatory neurons will 
be incubated with FGF22 then FGFR2 or FGFR1 will be immunoprecipitated and processed 
for proteomic analysis. Inhibitory neurons will be incubated with FGF7, then FGFR2 
immunoprecipitated and processed for proteomic analysis. 
B) To study the differences in the proteins recruited to the synapse by FGFR2b or FGFR1b, 
excitatory synaptoneurosomes will be isolated using fluorescence-activated 
synaptoneurosome sorting (FASS) to compare excitatory synapses by using proteomic 
analysis in the presence and absence of FGFRs, and inhibitory synaptoneurosomes will be 
isolated using FASS and compared with proteomic analysis to see the difference in the 






































immunoprecipitated proteins could be eluted and analyzed using electrospray ionization mass 
spectrometry (ESI-MS) (Gundry et al., 2009). In both cases, special protocols to target 
phosphoproteins could be used to identify phosphorylated proteins (Mann et al., 2002). In 
addition to downstream cytosolic proteins, it is possible that immunoprecipitation of the 
complexes will reveal interactions with other transmembrane proteins, such as an interaction of 
FGFR1 with NCAM (Dityatev et al., 2004). Understanding what proteins are recruited to FGFRs 
in response to synaptogenic activation will help shed light on the activated downstream signaling 
pathways (and relates strongly to question 1 in this section – dissecting the differences between 
FGFR2b and FGFR1b), and it will also help identify novel presynaptic proteins that may be 
associated with the FGFR signaling complex to induce presynaptic differentiation.  
It is possible that the presynaptic proteins affected by FGFR signaling will not be directly 
bound to the receptor, or may not remain bound to the receptor during immunoprecipitation. To 
gain a deeper biochemical understanding of synaptic vesicle recruitment, one would want to 
know how synaptogenic FGFR signaling affects the proteasome of excitatory or inhibitory 
presynaptic boutons. However the challenge is to isolate native excitatory and inhibitory 
synapses in order to narrow the experimental focus on the immediate vicinity of FGFR signaling. 
I propose to use fluorescence activated synaptoneurosome sorting (FASS) (Biesemann et al., 
2014), a modification of synaptoneurosome isolation (Hollingsworth et al., 1985), that would 
allow enrichment of selected excitatory or inhibitory synapses. Using the FASS protocol, one 
could isolate excitatory synaptoneurosomes from the hippocampal CA3 of FGFR-KO or WT 
animals expressing a fluorescently-tagged VGLUT1 and then sort using flow cytometry to enrich 
for VGLUT1-positive synaptoneurosomes. Excitatory synaptoneurosomes from FGFR1-KO, 
FGFR2-KO and control animals (or FGFR2b-het, FGFR1b-KO, and WT animals) would be 
isolated, to understand the specific roles of FGFR2b and FGFR1b in differentiating the 
excitatory presynaptic terminal. Isolation of inhibitory synaptoneurosomes would require 
crossing FGFR2-KO (conditional FGFR2-KO or FGFR2b-het) mice with mice that express a 
fluorescently-tagged VGAT, however fluorescently-tagged VGAT mice are not currently 
available. One possibility could be to use mice expressing YFP-labeled Neuroligin 2 (Soto et al., 
2011), which marks inhibitory postsynaptic densities (Varoqueaux et al., 2004). Another 
possibility is to sort synaptoneurosomes from the VGAT-Venus mice described in Chapter 4 
(Wang et al., 2009), but this would lead to enrichment for all of the synapses, excitatory and 
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inhibitory, onto the fluorescently-labeled interneurons because of fluorescent labeling of the 
postsynaptic side, in addition to inhibitory synapses onto CA3 pyramidal neurons. Once 
synaptoneurosomes were isolated from FGFR-KO and WT mice, the proteins could be run out 
using two-dimensional protein electrophoresis to identify differences in proteins; or, all of the 
immunoprecipitated proteins could be run on high throughput mass spectrometry. One potential 
problem may be that using fluorescently-tagged VGLUT1 will yield synaptoneurosomes with 
weaker fluorescence in the FGF22-KO, since they inherently have less accumulation. However, 
synaptic vesicle accumulation is not entirely abolished in FGF22-KO mice, and with proper 
thresholding, synaptoneurosomes may still be obtained. Another major limitation of isolating 
excitatory, and especially inhibitory synaptoneurosomes to perform proteomics is to obtain 
enough starting material for protein sequencing. However, if enough material can be obtained, by 
pooling samples from multiple animals, the results could yield novel substrates of FGFR 
signaling, and help clarify potential differences between mechanisms for recruiting synaptic 
vesicles in excitatory and inhibitory axon terminals. 
 
 
3. Probing possible roles of FGFRs in other cell types for presynaptic differentiation. 
  
I showed that FGF22 requires FGFR2b and FGFR1b that function presynaptically in the 
DGC, and FGF7 requires FGFR2b that functions presynaptically in interneurons to induce 
presynaptic differentiation (Dabrowski et al., 2015). However, FGF22 and FGF7 are secreted 
molecules, which means they can act on any cell in the vicinity of secretion, for example they 
could have an autocrine effect on the CA3 pyramidal neuron or act on astrocytes. Although I 
demonstrated presynaptic FGFR requirement for presynaptic function, by demonstrating their 
requirement in dentate granule cells and interneurons, I did not specifically exclude a function of 
FGFR2b and/or FGFR1b postsynaptically or in astrocytes in responding to FGF22 and FGF7. It 
is possible that FGFR2b and/or FGFR1b have additional roles in synapse development in 
response to CA3-derived FGFs. Indeed, Wnt7a, which induces presynaptic differentiation, acts 
on Frizzled receptors that are localized both presynaptically and postsynaptically (Salinas, 2012). 
To address whether FGFRs are required in other cell types in vivo to respond to FGF22 or 
FGF7, the best strategy would be to delete FGFRs in specific cell types by crossing the 
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conditional FGFR-KO mice with mice expressing cell-type specific, inducible Cre to delete the 
receptor in both a cell-type specific and temporally controlled manner, from P0 to P8, when 
presynaptic differentiation was assessed in the conditional FGFR-KO mice (Dabrowski et al., 
2015). Tamoxifen inducible Cre under a GFAP promoter (Ganat et al., 2006; Guo et al., 2011) 
can be used to delete floxed-FGFR2 or floxed-FGFR1 in astrocytes in vivo at birth, followed by 
measurement of excitatory and inhibitory presynaptic differentiation at P8 by using VGLUT1 
and VGAT, although a significant drawback of this strategy is that the Cre targets newborn 
neurons in the dentate gyrus as well as astrocytes, and dentate granule cells are important 
excitatory input onto CA3. Cre under the Grik4 promoter (Nakazawa et al., 2002) can delete 
floxed-FGFR2 or floxed-FGFR1 in CA3 neurons, postnatally, although a drawback may be weak 
expression in the first postnatal week. Deletion of FGFRs in astrocytes may affect presynaptic 
differentiation, since both FGFR2 and FGFR1 have been found to be important in the 
differentiation of astrocytes (Smith et al., 2006; Stevens et al., 2010a; 2010b; 2012), which may 
lead to presynaptic underdevelopment. Deletion of FGFR2 or FGFR1 in CA3 neurons may affect 
VGLUT1 accumulation, because CA3 neurons are synaptically interconnected (Witter, 2007), 
but should not affect VGAT accumulation.  On the other hand, I predict definite decreases in 
VGLUT1 after deletion of FGFR2 or FGFR1 in dentate granule cells by using Cre driven by the 
Pomc promoter (McHugh et al., 2007), and decreases in VGAT accumulation after deletion of 
FGFR2 from interneurons. Numerous strains of mice expressing inducible Cre under 
interneuron-specific promoters have been developed (Taniguchi et al., 2011), allowing not only 
functional localization of FGFR2 function to presynaptic interneurons, but also identification of 
which specific subtype of interneuron FGF7 is acting on.  
 
 
4. Cell-wide effects of FGF22-induced genes and FGF7-induced genes 
 
 In Chapter 4, I described an analysis of the changes in gene expression induced by 
FGF22 in DGCs and by FGF7 in interneurons. I also described preliminary results demonstrating 
that DGCs in FGF22KO mice have an increased density of dendritic spines in the 
suprapyramidal blade of the dentate gyrus. It is now important to demonstrate the mechanism 
through which these changes are occurring. My hypothesis is that FGF22 and FGF7 are acting as 
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target-derived cues from CA3 pyramidal neurons onto DGCs and interneurons, respectively, to 
promote aspects of neuronal and dendritic maturation through regulation of gene expression 
(Figure 4.1), analogous to the role of target-derived neurotrophins acting on sympathetic neurons 
in the peripheral nervous system (Harrington and Ginty, 2013). Thus, it will be important to 
interrogate the role of FGF22-and FGF7-induced genes in DGC and interneuron maturation. 
 The verification of the hypothesis that FGF22 is acting as a target-derived cue (see 
Figures 1.1 and 4.1) can be broken down into smaller, tractable experiments: 1) CA3-derived 
FGF22 is inducing candidate gene expression in DGC; 2) the candidate gene induces dendritic 
changes; and, if FGF22 is inducing dendritic changes: 3) the candidate gene is necessary for 
FGF22 to induce dendritic changes and 4) the candidate gene rescues dendritic changes in 
FGF22-KO.  
 To test whether CA3-derived FGF22 induces candidate gene expression in vitro, one can 
use two approaches: bath apply FGF22 to neuronal cultures, or apply FGF22 specifically to 
axons (mimicking a target-derived effect) by culturing DGCs in a microfluidic chamber, in 
which cell bodies are separated from axons (Taylor et al., 2005). Changes in gene expression 
(compared to untreated controls) can be detected by performing QPCR on the cultured neurons, 
or, alternatively by performing fluorescence-in situ hybridization on cultured neurons together 
with antibody staining for Prox1 to identify DGCs (Swanger et al., 2011). In a model of target-
derived effect, expression of candidate genes should be induced by FGF22 application both by 
bath application and axonal application.   
 To test the role of FGF22 and FGF22-induced genes on dendritic spine density in vitro, 
increases in dendritic spine density in FGF22-KO neurons in DGCs would first have to be 
observed in culture. (Defects described in Chapter 4 were in vivo.) Bath application of FGF22 
should “rescue” spine density and decrease density back to WT levels. The roles of individual 
genes could be assessed by using shRNA in culture – for the genes that are induced by FGF22, 
knockdown (for example with shRNA) in culture should lead to increased dendritic spine density 
(and for Adra2a, this has already been observed, e.g. Hu et al., 2008). If FGF22-KO DGC 
dendritic spine density is increased relative to control, overexpression of candidate genes should 
rescue the density to normal levels, and knockdown of candidate genes should prevent the 
decrease to WT levels by bath application of FGF22.  
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 The in vivo approach requires sophisticated genetic manipulations to selectively 
manipulate FGF22 expression in CA3 and candidate gene expression in the dentate gyrus. 
FGF22 is highly expressed in CA3, and also in the infrapyramidal blade of the dentate gyrus at 
P8 (Terauchi et al., 2010). Thus demonstrating that increased dendritic spine density or 
decreased neurogenesis is caused by target-derived FGF22 from CA3 will reinforce the model. 
To induce FGF22-deletion selectively in CA3, mice expressing Cre under a Grik4 promoter 
(Nakazawa et al., 2002) can be crossed with conditional FGF22-KO mice. First, CA3-selective 
FGF22-KO mice should be investigated for increases in dendritic spine density in the dentate 
gyrus and decreased adult neurogenesis, to establish whether FGF22 is acting as a target-derived 
cue. Next, to test whether CA3-derived FGF22 induces candidate gene expression in vivo, gene 
expression should be assessed in DGCs from CA3-selective FGF22-KO mice. To test whether 
candidate gene expression induces dendritic changes in vivo, it should be knocked down at P14 
(when genes were first identified; Chapter 4) in the dentate gyrus, for example by infecting 
dentate gyrus cells with lentivirus carrying shRNA, which should lead to increased dendritic 
spine density and/or decreased adult neurogenesis. Lentiviral overexpression of the candidate 
gene at P14 should have an opposite effect on dendritic spine density and/or adult neurogenesis, 
and should rescue the effect of CA3-selective FGF22-KO.  
Because FGF22-KO mice also display changes in adult neurogenesis (Lee and Umemori, 
2013), the change in dendritic spine phenotype may be due to a change in the population of 
DGCs, specifically an increased proportion of mature DGCs relative to immature DGCs. To test 
whether the change in density of dendritic spines is caused by a change in the proportion of 
mature and immature DGCs, neurons with the same “age” should be assessed. Retrovirus only 
infects dividing cells (Kron et al., 2010), and can be used to sparsely label neurons at P0 with 
GFP. DGCs in the suprapyramidal blade of the dentate gyrus born at the same time in FGF22-
KO and WT mice should be compared. 
Together, demonstrating effects of target-derived FGF22 on dentate gyrus neurogenesis 





5. What are the functional consequences of losing FGFR2b or FGFR1b in the hippocampal 
circuit? 
 
 Ultimately, the most important purpose of synapse formation is functional connectivity 
between neurons. I showed that FGFR2b-het mice and conditional FGFR2-KO mice have 
defects in both excitatory and inhibitory presynaptic differentiation, while FGFR1b-KO and 
conditional FGFR1-KO mice have defects only in excitatory, but not inhibitory presynaptic 
differentiation (Dabrowski et al., 2015). I did not show whether this led to functional changes 
within the circuit, which is a question worth asking on a broad level: Are electrophysiological 
defects demonstrable in FGFR-KO mice? Do FGFR-KO mice have altered connectivity in the 
hippocampus because of defective presynaptic differentiation? Do FGFR-KO mice have changes 
in hippocampal-dependent learning tasks caused by deficient presynaptic differentiation in CA3? 
Area CA3 is important for encoding spatial memory (Papp et al., 2007) and for pattern 
separation (Leutgeb and Leutgeb, 2007). Loss of excitatory drive from DG to CA3 and loss of 
inhibitory tone within CA3 may lead to defective information transfer through the circuit and 
defective pattern separation that is required for encoding memories or spatial information.  
 To answer whether FGFR-KO mice have functional synaptic defects, slice recordings 
from hippocampal slices of FGFR-KO mice and WT littermates could be used. First, to test 
whether there are excitatory or inhibitory synaptic defects, miniature excitatory postsynaptic 
currents (mEPSCs) or miniature inhibitory postsynaptic currents (mIPSCs) could be measured in 
CA3. mEPSC frequency is decreased in FGF22-KO mice, and mIPSCs frequency is decreased in 
FGF7-KO mice (Terauchi et al., 2010). By stimulating dentate granule cells and performing 
whole cell patch recordings in CA3 (e.g. Toth et al., 2000), paired-pulse facilitation at the mossy 
fiber synapse in CA3 could be measured to determine the readily-releasable pool of excitatory 
synaptic vesicles; and, with a high-frequency stimulation paradigm, long-term potentiation at the 
mossy fiber synapse of FGFR-KO and WT could be compared. Mechanisms of mossy fiber LTP 
remain controversial, but some researchers propose that it is induced by presynaptic changes 
(Nicoll and Malenka, 1995), so decreased excitatory presynaptic differentiation in FGFR2b-het 
and FGFR1b-KO mice could lead to changes in the induction of synaptic plasticity at the mossy 
fiber bouton. Understanding the relationship between FGFR-induced presynaptic differentiation 
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and its functional outcomes for plasticity will help shed light on what developmental 
mechanisms are required for forming a synapse capable of undergoing plasticity changes. 
 Next, the question of how loss of synaptogenic FGFR affects the hippocampal circuit 
connectivity comes up. Both FGFR2b and FGFR1b are required in DGCs to respond to FGF22 
(Dabrowski et al., 2015). However, at later stages of hippocampal circuit development, FGF22-
KO DGCs display dendritic defects, wherein they have increased dendritic spines (Chapter 4), 
which may affect the incorporation of DGCs into the hippocampal circuit and lead to decreased 
connectivity from the enthorhinal cortex (see Figure 1.1). Additionally, FGF22-KO display 
decreased adult neurogenesis (Lee et al., 2012). Do either of the FGFR-KO DGCs display 
defects in the dendritic spines or decreased neurogenesis due to loss of FGF22 signaling? To 
assess neurogenesis, the number of proliferating and immature DGCS in FGFR2b-het and 
FGFR1b-KO mice can be measured (see Lee and Umemori, 2013). Dendritic spines should be 
observed in FGFR2b or FGFR1b mice, for example by crossing them with the GFP-M strain of 
mice. A drawback is that FGFR signaling is promiscuous and responds to many ligands, not only 
FGF22, (e.g. Ornitz and Itoh, 2015), so the effects of FGFRs on circuit development may go 
beyond FGF22-dependent functions, and should be viewed as a function of the FGFR signaling 
itself. 
 Finally, connectivity in CA3 is important in a number of computational tasks, notably 
rapid one-trial contextual learning and pattern completion-based memory recall (Nakashiba et 
al., 2008). FGFR1b-KO mice have decreased excitatory presynaptic differentiation onto CA3, 
FGFR2b-het mice have, in addition to decreased excitatory differentiation, altered inhibitory 
presynaptic differentiation in CA3. GABAergic inhibition controls spike timing of pyramidal 
neurons (Mann and Paulsen, 2007). Furthermore, it is likely that, since FGF22-KO mice have 
decreased neurogenesis, either FGFR2b-het or FGFR1bKO mice have decreased adult 
neurogenesis, which is important for encoding pattern separation (Clelland et al., 2009; 
Nakashiba et al., 2012). FGFR1 is implicated in neurogenesis (Ma et al., 2009) and FGFR2 is 
implicated in differentiation, but not proliferation (Kang et al., 2009), but the isoform-specific 
contribution is unknown. It is likely that FGFR-KO mice will display defects in learning tasks 
that require hippocampal CA3, which include rapid encoding of information that can be tested, 
for example, on novel platform water maze tasks or contextual fear-conditioning (Kesner, 2007). 
Indeed, FGFR2-KO mice have impaired learning and memory (Stevens et al., 2010a, 2010b; 
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2012). I predict that FGFR2b-het and FGFR1b-KO mice will display deficits on specific 





6. FGF signaling in neurological diseases, with a focus on epilepsy. 
 
 Neurological diseases, such as epilepsy, have complicated etiologies. Temporal lobe 
epilepsy is caused by an interplay of a brain insult and genetic predisposition (Chang and 
Lowenstein, 2003; Noebels, 2015; Staley, 2015). Notably, brain trauma elicits a rearrangement 
of the hippocampal neural circuit that leads to progressive susceptibility to develop spontaneous 
seizures, a process known as epileptogenesis (Pitkanen and Lukasiuk, 2011). Current medication 
mainly targets seizures, but does not affect the underlying process of epileptogenesis (Chang and 
Lowenstein, 2003; Pitkanen and Lukasiuk, 2011). Thus, there is a need for targeted therapy to 
halt epileptogenesis.  
FGF22-KO mice and FGF7-KO mice display altered susceptibility to seizures (Terauchi 
et al., 2010; Lee et al., 2012; Lee and Umemori, 2013). They do not display spontaneous 
seizures, but have altered responses to seizure induction, thus making them good models for 
understanding the mechanisms of variable seizure susceptibility in the population. Furthermore, 
FGF22 and FGF7 are re-expressed after kainate-induced seizures (unpublished data), suggesting 
that their re-expression may have a role in shaping the post-seizure circuit that is increasingly 
prone to seizures. FGF22-KO and FGF7-KO mice may be informative models for understanding 
the molecular events underlying epileptic network rearrangement and for finding treatments 
targeting epileptogenesis.  
 In order to better understand the role of FGFRs in epileptogenesis several experiments 
can be performed. Do FGFR2b-het and FGFR1b-KO mice have seizure phenotypes? Loss of 
FGFR2b affects both FGF22-induced excitatory synapses and FGF7-induced inhibitory 
synapses: thus, it could lead to heightened seizure sensitivity, resistance, or neither. FGFR1b-KO 
mice should be seizure-resistant, since they are predominantly responding to FGF22 to induce 
excitatory presynaptic differentiation. If FGFR1b-KO mice do not have a change in seizure 
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susceptibility, this suggests that FGR2b is responsible for FGF22-induced changes in seizure 
susceptibility. On the other hand if FGFR1b-KO mice are seizure resistant, targeting FGFR1b 
signaling or FGF22 interaction with FGFR1b signaling may prove to be an important, and 
specific, therapeutic target.  
 Another important question is whether FGF22 functioning early during development or 
FGF22 re-expressed after seizures is key to promoting seizure susceptibility. To address this, 
conditional FGF22-KO mice can be crossed with inducible Cre mice to delete FGF22 either at 
P0 (to target developmental presynaptic differentiation) or concurrently with seizure kindling (to 
target pathological synaptic remodeling). If FGF22-deletion at kindling does not alter seizure 
susceptibility, that suggests that FGF22 activity during synaptogenesis predisposes the circuit to 
seizures. However, if FGF22-deletion at kindling causes resistance to seizure induction, this 
suggests that FGF22 re-expressed in response to seizures drives epileptogenesis. This outcome 
would suggest that targeting FGF22 could have therapeutic benefit. 
 Finally, FGF22 induces the expression of a number of genes that have roles in neural 
circuit remodeling (Chapter 4). Do FGF22-induced genes have a role in epileptogenesis? FGF22 
re-expressed during kindling may be required for epileptogenic hippocampal circuit changes; it 
may also induce gene expression that leads to the circuit remodeling. FGF22-KO mice do not 
develop full seizures, even with an extended kindling protocol (Terauchi et al., 2010; Lee and 
Umemori, 2013), which makes it unfeasible to obtain a post-seizure sample from FGF22-KO to 
compare to post-seizure WT mice. However, the genes induced by FGF22 during development 
may be re-expressed after seizures, so it may be worthwhile to understand the roles of the 
FGF22-induced genes both in neural circuit development (Chapter 4), and in epileptogenesis. If 
targeting FGF22 proves to be a technically difficult strategy, targeting one of the downstream 





 The circuitry of the brain is incredibly complex and the mechanisms governing the 
startling accuracy with which the brain develops are being uncovered. Specific neuronal circuits 
are being parsed out with the help of optogenetic manipulation of individual neuron excitability, 
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viral gene expression, and sophisticated genetic mouse models (Steinberg et al., 2015). The 
trajectory of individual neurons incorporating into the neuronal circuits is being traced with 
increasing accuracy (e.g. Ge et al., 2006). And increasingly sophisticated studies have yielded an 
increase in the number of identified synaptogenic molecules (de Wit and Ghosh, 2014; Williams 
and Umemori, 2014; Dabrowski and Umemori, 2011). It will be important to understand 
formation of synapses within the context of an ever-changing circuit, where everything is, in the 
end, connected. So far, synaptogenic molecules within the central nervous system have been 
characterized primarily for their local effects at inducing synapse formation. Understanding the 
signaling through which synapses develop, and the potential effect of synapse development on 
the integration of neurons within the circuit (see Figure 1.1), will help shed light on the 
emergence of highly specific, functioning neuronal circuits. In this context, my work on 
identifying the receptors and the mechanisms through which FGF22 and FGF7 induce specific 
presynaptic differentiation (Dabrowski et al., 2015), and my work towards understanding gene 
expression and cell wide changes induced by the synaptogenic FGFs will make important 
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